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Executive summary
This is the fifth report of the national clinical 
audit on perinatal mortality in Ireland using 
the NPEC data collection tool and classification 
system. Anonymised data were reported 
by the 19 Irish maternity units on a total of 
488 deaths arising from 65,904 births that 
occurred in 2015, of at least 500g birthweight 
and/or at least 24 weeks gestation.
Stillbirths, early neonatal and late neonatal 
deaths accounted for 294 (60.2%), 166 
(34.0%) and 28 (5.7%) of the 488 deaths, 
respectively. The perinatal mortality rate 
was 7.0 deaths per 1,000 births; corrected 
for congenital anomaly, the rate was 4.3 per 
1,000 births; the stillbirth rate was 4.5 per 
1,000 births; and, the early neonatal death 
rate was 2.5 per 1,000 live births. 
Applying the guideline of reporting perinatal 
deaths with a birthweight of at least 500g 
irrespective of gestation, as the Irish 
Healthcare Pricing Office does in reporting 
national perinatal statistics,1  there were 262 
stillbirths (4.0 per 1,000 births) and 164 early 
neonatal deaths (2.5 per 1,000 live births) in 
2015.
A recent paper published in the Lancet’s 
Ending Preventable Stillbirths Series, 
compared the stillbirth rate across 48 high-
income countries.2 The Lancet study used 
the gestational age criterion of ≥ 28 weeks. 
Applying the gestational age criterion of ≥ 
28 weeks, Ireland’s uncorrected stillbirth 
rate was 3.4 per 1,000 births and when 
corrected by excluding cases due to a 
congenital anomaly, is adjusted to 2.5 per 
1,000 births.
Similar to 2014, major congenital anomaly 
was the primary cause of death in over one in 
four (n=79, 26.9%) of the 294 stillbirths that 
occurred in 2015. There was a chromosomal 
disorder in over sixty percent of the 79 
stillbirths due to congenital anomaly (n=52, 
65.8%). A placental condition, was the main 
cause of death in one in four of stillbirths 
(n=71, 24.1%), the most commonly occurring 
placental condition was maternal vascular 
malperfusion (n=26 of 71, 36.6%). For sixteen 
percent of stillbirths (n=46, 15.6%), the cause 
of death was unexplained. This is similar to 
the proportion in 2014 (n = 49, 14.8%) but 
lower than the proportion in 2013 (26.3%) and 
in 2012 (22.7%).
Major congenital anomaly was the primary 
cause of death for almost sixty percent (n=98, 
59.0%) of the 166 early neonatal deaths. 
Respiratory disorder was the second most 
common cause of death, accounting for almost 
one in four (n=41, 24.7%) of early neonatal 
deaths of which the majority (n=31, 75.6%) 
were due to severe pulmonary immaturity.
In Ireland in 2015, an autopsy was undertaken 
following 55.3% of stillbirths (n=162 of 293, 
unknown for one case) and 41.5% of early 
neonatal deaths (n=66 of 159, unknown for 
seven cases). 
The mothers who experienced perinatal loss 
in 2015 ranged in age from teenage years 
through to late-forties. Their age distribution 
broadly reflected that of the population of 
mothers who gave birth in Ireland. Over half of 
the population (54.9%) who gave birth in 2015 
were aged 25-34 years.
1 Healthcare Pricing Office. (2017) Perinatal Statistics Report 2015. Dublin: Health Service Executive [in press]
2 Flenady V, Wojcieszek AM, Middleton P, Ellwood D, Erwich JJ, Coory M, Khong TY, Silver RM, Smith GC, Boyle FM, Lawn JE, 
Blencowe H, Leisher SH, Gross MM, Horey D, Farrales L, Bloomfield F, McCowan L, Brown SJ, Joseph KS, Zeitlin J, Reinebrant HE, 
Ravaldi C, Vannacci A, Cassidy J, Cassidy P, Farquhar C, Wallace E, Siassakos D, Heazell AE, Storey C, Sadler L, Petersen S, Frøen 
JF, Goldenberg RL; Lancet Ending Preventable Stillbirths study group; Lancet Stillbirths In High-Income Countries Investigator 
Group. Stillbirths: recall to action in high-income countries. Lancet 2016; 387: 691–702.
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In terms of ethnicity and occupation, while 
the numbers involved were small, ethnic 
minorities and the unemployed were over-
represented in the mothers who experienced 
perinatal deaths: this is similar to findings in 
2014. Monitoring the socio-economic status 
of the pregnant population in Ireland is 
challenging as these data are not routinely 
captured in Irish maternity records, but 
further efforts must be made if we are to 
better understand how social disadvantage 
impacts on perinatal outcomes. 
Smoking status of the mothers at their time 
of booking was recorded for 430 (93.5%) 
of the 460 women. Of these, 87 (20.2%) 
were smokers at the time of booking. Most 
were smoking at least 10 cigarettes per day 
(n=50 of 68, 73.5%; unknown for 19 cases). 
Information on smoking in late pregnancy was 
available for 58 of the 87 smokers (66.7%); six 
(10.3%) stopped smoking during pregnancy.
Body mass index (BMI) was available for 
90.4% (n=416) of women who experienced 
perinatal loss in 2015. The BMI of 43.8% of 
these mothers was in the healthy range 
(18.5-24.9kg/m2), which is similar to 
previous years. Over the last five years, 2011-
2015, 53.3% of the mothers who experienced 
perinatal loss were either overweight or obese 
albeit with fluctuation in the distribution of 
these two groups.
Seventy percent of mothers who experienced 
perinatal loss in 2015 had at least one previous 
pregnancy (324 of 460, 70.4%) and nearly 
thirty percent (n=136, 29.6%) had never been 
pregnant before. In terms of parity, women 
who experienced perinatal loss in 2015 were 
similar to the population of women who gave 
birth in 2015. 
The NPEC Notification Form contains a 
specific question on whether the pregnancy 
resulting in perinatal loss was the result of 
fertility treatment. In 2015, information was 
available for 423 of the 460 (91.9%) cases of 
perinatal death. In 33 of these cases (7.8%) 
the pregnancy was reported to be the result 
of fertility treatment (n=21 of 269 stillbirths, 
7.8 %; n=12 of 154 early neonatal deaths, 
7.8%). Twenty three of these 33 pregnancies 
(69.6%) were associated with multiple births 
ending in perinatal loss of one or more 
infants.
There were 68 perinatal deaths from 
multiple births, making up 14.8% of all 
perinatal deaths in 2015. This is 3.9 times the 
proportion of multiples among all births in 
2015 (3.8%).
For women who experienced perinatal 
loss in 2015, forty one (9.1%) were 
admitted to a high dependency unit (HDU) 
and nine (2.0%) were admitted to an 
intensive care unit (ICU).  
There were 28 late neonatal deaths in 
2015 reported to the NPEC. Similar to early 
neonatal deaths, over half of late neonatal 
deaths were due to major congenital 
anomaly (n=15, 53.6%). Infection was 
the second most common cause of 
death, accounting for 14% of late neonatal 
deaths (n=4, 14.3%). As with previous 
years, the proportion of late neonatal 
deaths was found to decrease across 
the second, third and fourth weeks of life.
In summary, the findings of this 
national clinical audit of perinatal mortality 
highlight the inherent need for on-going 
audit in order to identify key factors 
impacting on adverse perinatal outcomes. 
The need for prevention extends beyond 
the maternity services: there is 
requirement for a public awareness 
programme. Potential parents must also 
be made aware of the modifiable risk factors 
for perinatal mortality, with a view to 
improving their health and lifestyle prior to 
pregnancy.
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3 Khong TY, Mooney EE et al (2016). Sampling and definition of placental lesions. Arch Pathol Lab Med 2016 Jul;140 (7):698-713
4 Clinical Practice Guideline No 29 (2014). Fetal Growth Restriction Guideline - Recognition, Diagnosis and Management: Institute of Obstetricians and 
Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive.
Recommendations
• All Irish maternity units now collect and submit data
on perinatal deaths to inform the maternity services
through the NPEC national audit on perinatal
mortality. Whilst this is encouraging, the NPEC would
like to stress the importance of ongoing submission
of data on all neonatal deaths regardless of
gestational age or weight at birth.
• With the support of the Faculty of Pathology, the
NPEC have adapted the standardised terminology3, as
recommended at an international consensus
meeting of pathology, in presenting the placental
findings in cases of stillbirth and neonatal death.
• The establishment of a confidential enquiry for
stillbirth and neonatal death should be considered
in order to enhance the lessons which may improve
care.  An initial step would be the establishment of
a standardised review of a case series of unexpected
perinatal deaths associated with intrapartum events.
• Improved antenatal detection of fetal growth
restriction (FGR) with timely delivery is a preventative
strategy to reduce perinatal mortality.4 The
generation of customized birth weight centile charts
for every woman during pregnancy is recommended
and concomitantly, staff should be trained to plot
symphysial fundal height (SFH) and scan weight
estimates in order to reduce stillbirths in Ireland.
• Resourcing of perinatal pathology services on a
regional and national basis, as recommended by
the Faculty of Pathology would provide equal access
to review for all perinatal deaths nationally and
would facilitate an agreed approach to classification
of autopsy, placental histology and cytogenetics.
• Anonymised placental histology reports on perinatal
death should be submitted to the NPEC as part of this
audit: this would facilitate standardised interpretation
and classification of placental conditions.
• Further research exploring factors impacting on
autopsy rates, particularly in the case of neonatal
deaths, is warranted.
• NPEC supports the Institute of Obstetrics and
Gynaecology in the recommendation that anatomy
ultrasound is available universally in Ireland. This
point is further highlighted in the Invited Commentary
of the Perinatal Mortality in Ireland Annual Report
2015.
• Funding should be provided by the Health Service
Executive (HSE) to ensure that staffing levels allow
protected time for clinical audit. Robust clinical audit
of perinatal outcomes in all maternity units in Ireland
is vital for patient care, but such audit requires the
protected time of clinical staff.
• A public health education programme on perinatal
deaths and modifiable risk factors should be
developed.
Recommendations actioned following the publication of 2013 and 2014 reports:
Based on the findings of this report, the NPEC Perinatal Mortality Advisory Group 
makes the following recommendations:
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Data collection and management
In 2015, there were 19 maternity units 
in Ireland. Anonymised data on perinatal 
deaths from births that occurred between 
January 1 and December 31 2015 were 
submitted to the NPEC by all 19 units using 
a standardised notification dataset either 
electronically, via the secure online NPEC 
database, or alternatively by paper format 
(see Appendix E). This detailed notification 
dataset, implemented nationally in 2011, was 
based on the validated Centre for Maternal 
and Child Enquiries (CMACE) Perinatal Death 
Notification Form5 and has been endorsed by 
the Clinical Advisory Group at the Institute of 
Obstetrics and Gynaecology, the Faculty of 
Paediatrics and the HSE National Obstetric 
Programme Working Group. 
Figure 1 illustrates the NPEC data collection 
and management processes. To ensure 
completeness and accuracy of information, all 
data is validated directly with the respective 
maternity units. The NPEC also undertakes 
extensive reconciliation of its annual perinatal 
mortality dataset with that of the National 
Perinatal Reporting System (NPRS). This 
consolidation with the NPRS is in response 
to recommendations by the Chief Medical 
Officer5 and ensures that both agencies 
datasets represent the most accurate record 
of perinatal mortality annually.
Definitions and terminology
While individual units define perinatal cases 
similarly, there is some variation. To allow for 
comparison across all units the NPEC used 
the following definitions for the current report.
Baby Live birth: Live birth refers to the 
complete expulsion or extraction from 
its mother of a product of conception, 
irrespective of the duration of the pregnancy, 
which, after such separation, breathes or 
shows any other evidence of life - e.g. beating 
of the heart, pulsation of the umbilical cord 
or definite movement of voluntary muscles 
Methods
Figure 1: NPEC data collection and management processes.
• Designated Unit Coordintor submits data to the NPEC
• Possible Contributors:
• Midwives
• Obstetricians
• Neonatal Nurses
• Neonatologists
• Pathologists
• Stillbirth or neonatal death occurs
• NPEC data manager reviews and validates all data with
the unit co-ordinator
• Consolidation of the NPEC data with the
National Perinatal Reporting System (NPRS) dataset
• Data cleaning and validation
• Data analysis and report writing
• Review and endorsement of the report by: NPEC Perinatal
Mortality Advisory Group, NPEC Governance Committee and
the National Oﬃce of Clinical Audit
• Dissemination of the national report to various stakeholders and
the public
• Dissemination of unit speciﬁc reports to all maternity units
Maternity Unit 
Completes NPEC 
Perinatal Death 
Notiﬁcation Dataset 
Perinatal Death
Data Management 
and Quality 
Assurance
Annual Perinatal 
Mortality Report 
Produced
5 Centre for Maternal and Child Enquiries (CMACE) (2010) Perinatal Mortality 2008: United Kingdom. London: CMACE
6 Holohan, T. (2014) HSE Midland Regional Hospital, Portlaoise Perinatal Deaths (2006-date). Dublin: Department of Health. Available at: http://www.lenus.ie/
hse/bitstream/10147/313524/1/portlaoiseperinataldeaths.pdf
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- whether or not the umbilical cord has been
cut or the placenta is attached. Each product
of such a birth is considered live born.7
Total births: For the purpose of calculating 
perinatal mortality rates, the denominator 
used is the number of births (live birth and 
stillbirths) from 24 weeks gestation and/or 
birthweight ≥500g.
Stillbirth: Baby delivered without signs of life 
from 24 weeks gestation or with a birthweight 
≥500g, in accordance with current legislation
on stillbirth registration in Ireland.8
Early neonatal death: Death of a live born baby 
occurring within 7 completed days of birth.
Late neonatal death: Death of a live born baby 
occurring after the 7th day and within 28 
completed days of birth.
Stillbirth rate: Number of stillbirths per 1,000 
births (live births and stillbirths from 24 
weeks gestation and/or weighing ≥500g). 
Neonatal death rate: Number of early neonatal 
deaths per 1,000 live births (from 24 weeks 
gestation and/or weighing ≥500g). Live born 
infants <24 weeks gestation and <500g are 
not included. 
Overall perinatal mortality rate (PMR): Number 
of stillbirths and early neonatal deaths per 
1,000 births (live births and stillbirths from 
24 weeks gestation and/or weighing ≥500g). 
Corrected PMR: Perinatal mortality rate 
excluding perinatal deaths due to a major 
congenital anomaly. Major congenital anomaly 
defined as any genetic or structural defect 
arising at conception or during embryogenesis 
incompatible with life or potentially treatable 
but causing death. 
Booking: Some data sought by the NPEC 
Perinatal Death Notification Form relate to the 
time of booking. Booking in this regard relates 
to the mother’s first antenatal visit at the 
maternity unit.
In utero transfer: The NPEC Perinatal Death 
Notification Form records the intended place 
of delivery at the time of the mother’s first 
antenatal visit and the intended place of 
delivery at onset of labour. For cases where 
the intended place of delivery at booking 
differed from the intended place of delivery 
at onset of labour it was presumed that the 
care of the mother was transferred in utero, 
i.e. the mother was transferred to the care of
another maternity unit where her baby was
delivered. From 2016, in utero transfer in the
maternal or fetal interest will be ascertained
by a specific question on the NPEC Perinatal
Death Notification Form.
Parity: The number of completed pregnancies, 
whether live birth or stillbirth, of at least 24 
weeks gestation and/or with a birthweight 
≥500g. We refer to parity prior to the
pregnancy that resulted in a perinatal loss in
2015.
Gravida: The number of times the mother has 
been pregnant, irrespective of duration. We 
refer to gravida prior to the pregnancy that 
resulted in a perinatal loss in 2015.
Classification of abnormal placental histology: 
Abnormal placental findings have been 
classified and are presented under the 
following broad categories: maternal vascular 
malperfusion, fetal vascular malperfusion, 
cord pathology, delayed villous maturation 
defect, chorioamnionitis, villitis and other. 
This is in keeping with recommendations in a 
publication from an international consensus 
meeting of pathology.9 It is envisaged that 
this will optimise classification of placental 
conditions causing or contributing to perinatal 
loss.
7 World Health Organisation. Available at: http://www.who.int/healthinfo/statistics/indmaternalmortality/en/
8 Stillbirths Registration Act, 1994.
9 Khong TY, Mooney EE et al (2016). Sampling and definition of placental lesions. Arch Pathol Lab Med 2016 Jul;140 (7):698-713
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Classification of death
The NPEC data collection form requests 
contributors to identify maternal, fetal and 
neonatal conditions, using specific categories, 
which caused or were associated with the 
death. The unit contributor is also requested 
to assign the principal cause of death with 
reference to the post mortem and placental 
pathology if performed. Guidance and 
definitions for completing specific categories 
are described in Appendix G. Briefly described, 
categories include both pathophysiological 
entities and clinical conditions present at 
time of death including placental pathology 
and Intra-Uterine Growth Retardation (IUGR). 
Classification of stillbirths was made using 
the NPEC maternal and fetal classification 
system. In the case of neonatal deaths, the 
NPEC neonatal classification system was 
used to attribute the main neonatal cause 
of death and the NPEC maternal and fetal 
classification system was used to identify 
the underlying obstetric condition/sentinel 
event associated with the death. A notable 
difference in the NPEC neonatal classification 
system is that neonatal deaths occurring after 
22 weeks gestation, previously attributed to 
prematurity, would most often be captured 
under the subcategory of severe pulmonary 
immaturity.
Rate calculations
To assess perinatal mortality, overall and 
unit-specific perinatal mortality rates (PMRs) 
per 1,000 births and corresponding 95% 
confidence intervals based on the normal 
approximation of the Poisson distribution 
were derived. Stillbirth, neonatal and 
corrected PMRs, which exclude deaths due to 
a congenital anomaly, were also calculated. 
Denominator data on the number of live births 
and stillbirths were provided directly by the 
Healthcare Pricing Office (HPO). Perinatal 
deaths are included in a maternity unit’s rate 
if the baby was delivered in the maternity 
unit or if the unit was the intended place of 
delivery but the baby was born before arrival. 
Funnel plots
Variations in PMRs between maternity units 
could potentially be due to random chance or 
reflect differences in baseline characteristics 
of the childbearing population. For this reason, 
funnel plots were used to assess performance 
outcomes for individual units in comparison 
to the overall average.10 In brief, the plot is a 
scatter diagram of individual maternity unit 
mortality rates against the number of births 
within that unit. The overall mortality rate 
is indicated by the solid straight line and 
the corresponding 95% confidence interval 
is indicated by the curved dashed line. The 
confidence interval is wider for smaller units, 
which are more prone to variable estimates 
and gradually narrows as the unit size 
increases, hence, giving the diagram a ‘funnel’ 
shape. Maternity units with mortality rates 
lying outside the 95% confidence interval 
are statistically significantly different from 
the overall average. In general, there is a one 
in 20 chance that one of the units would be 
expected to lie outside the 95% confidence 
interval due to chance alone.
Birthweight centile
As with previous reports, we have produced 
charts to highlight the issue of failure of fetal 
growth in utero in relation to the stillbirths and 
early neonatal deaths that occurred in Ireland 
in 2015. To do so, we used the Gestation 
Related Optimal Weight (GROW) software11 
and coefficients derived from the multiple 
regression analysis of data on 11,072 births 
in six maternity units in Dublin, Galway, 
Limerick and Belfast in 2008-2009.12
The regression analysis determined the 
Term (i.e. 40 weeks) Optimal Weight (TOW) 
in Ireland to be 3,490.7g. The normal range 
(i.e. the range from the 10th centile weight 
10 Spiegelhalter D. (2002) Funnel plots for institutional comparison. Quality and Safety in Health Care; 11(4):390-91.
11 Gardosi J, Francis A. Customised Weight Centile Calculator. GROW version 6.6, 2013 Gestation Network, www.gestation.net
12 Unterscheider J, Geary MP, Daly S, McAuliffe FM, Kennelly MM, Dornan J, Morrison JJ, Burke G, Francis A, Gardosi J, Malone FD. 
The customized fetal growth potential: a standard for Ireland. Eur J Obstet Gynecol Reprod Biol 2013; 166(1):14-7
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to the 90th centile weight) around the TOW 
was then calculated and the recommended 
proportionality growth function was applied 
to the TOW, the 10th centile term weight 
and the 90th centile term weight in order to 
determine the optimal weight and normal 
range at all gestations (21-44 weeks for the 
stillbirths and early neonatal deaths in Ireland 
in 2015). These steps are described in detail 
in the GROW documentation.
Customised birthweight centiles were also 
derived using the GROW software. There was 
missing data for maternal height and weight 
with one or both unknown for 10.0% of the 
mothers (n=46). For these cases, we used 
the median height and weight of the mothers 
with complete data. The GROW software also 
provides estimated customised birthweight 
centiles in cases with missing data. 
Ultimately, customised birthweight centiles 
were calculated for 459 of the 460 mothers 
(99.8%).
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1. Main findings
This section of the report provides details of the 
perinatal mortality rate (PMR), maternal and 
infant characteristics and autopsy uptake. In line 
with previous reports, the findings provided in 
this section relate to stillbirths and early neonatal 
deaths only. Separate sections are then provided 
for stillbirths, early neonatal deaths and late 
neonatal deaths describing clinical management 
and the main cause of death based on the NPEC 
Classification System.
Current legislation on stillbirth registration in 
Ireland is based on the criteria of birthweight 
≥500g or gestation at delivery ≥24 weeks.
Using these criteria, the 19 Irish maternity units
reported 65,904 births, of which 488 were
subsequently classified as perinatal deaths.
Stillbirths, early neonatal and late neonatal
deaths accounted for 294 (60.2%), 166 (34.0%) 
and 28 (5.7%) of the 488 deaths, respectively.
The reporting guideline used by the Irish 
Healthcare Pricing Office in their publication 
of national perinatal statistics, uses the 
criterion of birthweight ≥500g. In 2015, the 
19 Irish maternity units reported 65,869 
births weighing ≥500g of which 453 were 
subsequently classified as perinatal deaths. 
Stillbirths, early neonatal and late neonatal 
deaths accounted for 262 (57.8%), 164 (36.2%) 
and 27 (6.0%) of the 453 deaths, respectively.
Thus, it can be seen that while broadening the 
inclusion criteria has a negligible impact on the 
total number of births, (n=35) it increased the 
number of stillbirths by 12.2% (from 262 to 294, 
n=32) and early neonatal deaths by 1.2% (from 
164 to 166, n=2). This is also evident for the rate 
of each perinatal mortality outcome as detailed in 
Table 1.1.
The stillbirth rate associated with the criteria of 
birthweight ≥500g and/or delivery gestation ≥24 
weeks was 4.5 per 1,000 births and the early 
neonatal death rate using the same criteria was 
2.5 per 1,000 live births compared respectively 
to 4.0 and 2.5 per 1,000 births based on 
birthweight ≥500g. The overall PMR was 7.0 
deaths per 1,000 births and when corrected for 
congenital anomaly was reduced to 4.3 whereas 
the respective rates based on birthweight ≥500g 
were 6.5 and 4.0 per 1,000 births.
Table 1.1: Frequency and rate of perinatal mortality outcomes, 2015
Note: BWT=Birthweight; Rate per 1,000 births; 95% CI=95% confidence interval; Corrected perinatal deaths exclude deaths 
due to a congenital anomaly.
Perinatal mortality rate
BWT ≥500g or delivery ≥24 weeks BWT ≥500g
Number Rate (95% CI) Number Rate (95% CI)
Total births 65,904 65,869 
Stillbirths 294 4.5 (3.9-5) 262 4.0 (3.5-4.5)
Early neonatal deaths 166 2.5 (2.1-2.9) 164 2.5 (2.1-2.9)
Perinatal deaths 460 7.0 (6.3-7.6) 426 6.5 (5.8-7.1)
Corrected perinatal deaths 283 4.3 (3.8-4.8) 261 4.0 (3.5-4.5)
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Note: Rates based on stillbirths among births with ≥28 completed weeks of gestation. *indicates countries with fewer than 
5000 births. The Irish stillbirth rate, when corrected by excluding cases due to a congenital anomaly, is adjusted to 2.5. 
A paper recently published in the Lancet’s 
Ending Preventable Stillbirths Series, 
compared the stillbirth rate across 48 high-
income countries.13 This Lancet study used the 
gestational age criterion of ≥ 28 weeks. Figure 
1.1 illustrates the 2015, Irish stillbirth rate and 
the corrected Irish stillbirth rate excluding 
cases due to a congenital anomaly compared 
to the reported stillbirth rate for the other 48 
high-income countries. 
International comparison of the rate of stillbirth
13  Flenady V, Wojcieszek AM, Middleton P, Ellwood D, Erwich JJ, Coory M, Khong TY, Silver RM, Smith GC, Boyle FM, Lawn JE, Blencowe H, Leisher SH, Gross MM, 
Horey D, Farrales L, Bloomfield F, McCowan L, Brown SJ, Joseph KS, Zeitlin J, Reinebrant HE, Ravaldi C, Vannacci A, Cassidy J, Cassidy P, Farquhar C, Wallace E, 
Siassakos D, Heazell AE, Storey C, Sadler L, Petersen S, Frøen JF, Goldenberg RL; Lancet Ending Preventable Stillbirths study group; Lancet Stillbirths In High- 
Income Countries Investigator Group. Stillbirths: recall to action in high-income countries. Lancet 2016; 387: 691–702.
Figure 1.1: Irish stillbirth rate in 2015 compared to the reported stillbirth rate for the other 48 
high-income countries
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Table 1.2 compares the perinatal mortality 
outcomes for 2015, based on the criteria 
of birthweight ≥500g and/or gestation at 
delivery ≥24 weeks, with those of the previous 
four years. There are some issues relevant to 
the comparability of the data. Data were based 
on 19 maternity units for 2015, due to the 
closure of one unit, but were based on all 20 
maternity units for years 2011-2014. 
The stillbirth rate and the corrected PMR were 
8.2% and 8.5% lower in 2015 than in 2014. 
Whereas, the early neonatal death rate was 
19.0% higher in 2015 than in 2014. The PMR 
rate was the same in 2014 and 2015. 
The time trend in each of the perinatal 
mortality rates is illustrated in Figure 1.2. 
There is no predominant trend over the five 
year period. There was a decreasing trend 
in the initial years of the period, a trend that 
had been observed for a number of decades 
in Ireland. However, it appears that this 
longstanding decreasing trend has ended in 
recent years.
Table 1.2: Comparison of perinatal statistics, 2011-2015
2011 2012 2013 2014 2015 
Total births 74,265 71,755 69,146 67,663 65,904
Perinatal deaths 456 445 463 471 460
Stillbirth rate 4.3 4.2 4.4 4.9 4.5
Neonatal death rate 1.9 2.0 2.4 2.1 2.5
PMR 6.1 6.2 6.7 7.0 7.0
(95% CI) (5.6-6.7) (5.6-6.8) (6.1-7.3) (6.3-7.6) (6.3-7.6)
Corrected PMR 4.1 4.1 4.4 4.7 4.3
(95% CI) (3.6-4.5) (3.7-4.6) (3.9-4.9) (4.2-5.2) (3.8-4.8)
Comparison of perinatal mortality, 2011-2015
Note: 2015 data are based on 19 maternity units due to the closure of one unit, whereas others years’ data are based on 20 
maternity units; Rates per 1,000 births; PMR= perinatal mortality rate; 95% CI=95% confidence interval; Corrected PMR excludes 
deaths due to a congenital anomaly.
Figure 1.2: Trend in perinatal mortality rates in Ireland, 2011-2015
Note: 2015 are based on 19 maternity units whereas others years’ data are based on 20 maternity units; Rates per 1,000 births; 
PMR = perinatal mortality rate; Corrected PMR excludes deaths due to a congenital anomaly.
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Based on birthweights ≥500g and/or gestation 
at delivery ≥24 weeks, the uncorrected PMR 
across the Irish maternity units ranged from 
2.5 to 8.9 per 1,000 births (Table 1.3); the 
corrected PMR ranged from 1.9 to 6.1 per 
1,000 births. This level of variation is similar 
to that observed in the corrected PMR across 
units in recent years.
While there was a decrease in the corrected 
PMR at the national level from 4.7 per 1,000 
births in 2014 to 4.3 per 1,000 births in 2015, 
there were of course fluctuations at the level 
of the individual maternity units. There was 
little correlation between the unit-specific 
corrected PMR in 2014 and 2015. 
Variation by maternity unit
Table 1.3: Perinatal mortality rates across Irish maternity units in 2014 and 2015
Unit  Uncorrected PMR (95% CI) Corrected PMR (95% CI)
2015 2015 2014
1  8.9(6.9-10.9) 5.1(3.6-6.7) 5.6(4-7.1)
2  8.5(5.3-11.7) 6.1(3.4-8.8) 4.4(2.1-6.7)
3  8.0(3.9-12.1) 5.8(2.3-9.4) 6.1(2.6-9.6)
4  7.4(2.7-12) 5.9(1.7-10.1) 5.0(1.2-8.7)
5  7.4(3.3-11.5) 5.1(1.7-8.5) 1.8(0-3.8)
6  7.4(3.6-11.2) 3.4(0.8-6) 5.2(2.1-8.3)
7  7.2(4.7-9.7) 3.6(1.9-5.4) 4.2(2.3-6.1)
8  7.2(5.3-9) 4.8(3.3-6.3) 4.3(2.9-5.8)
9  7.1(4-10.1) 4.4(1.9-6.8) 5.0(2.4-7.6)
10 7.0(5.3-8.8) 4.3(2.9-5.6) 4.7 (3.3-6.1)
11 6.8(3.3-10.3) 5.0(2-8) 6.2(3-9.4)
12 6.4(2.5-10.2) 3.5(0.6-6.3) 4.0(1-6.9)
13 6.4(2.7-10.1) 2.7(0.3-5) 2.5(0.3-4.8)
14 6.3(4.6-8.0) 3.6(2.3-4.9) 4.8(3.3-6.2)
15 6.2(2.3-10.2) 5.0(1.5-8.5) 5.8(2.1-9.4)
16 5.7(1.7-9.7) 2.8(0-5.7) 1.4(0-3.3)
17 4(1.0-7.1) 2.9(0.3-5.5) 4.4(1.3-7.6)
18 3.8(0-7.5) 2.8(0-6.1) 2.7(0-5.9)
19 2.5(0-5) 1.9(0-4) 5.5(2-8.9)
All 7.0(6.3-7.6) 4.3 (3.8-4.8) 4.7(4.2-5.2)
Note: Rates per 1,000 births based on birthweights ≥500g and/or gestation at delivery ≥24 weeks; PMR=perinatal mortality 
rate; 95% CI=95% confidence interval; Corrected PMR excludes deaths due to a congenital anomaly.
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Figure 1.3: Funnel plot of the corrected perinatal mortality rate for Irish maternity units, 2015
The profile of mothers delivered may differ 
across Irish maternity units and this may explain 
variation in perinatal mortality rates. However, to 
establish this requires more detailed information 
on all mothers delivered at Irish maternity units 
than is currently available.
The solid horizontal line in Figure 1.3 represents 
the national corrected PMR in 2015 (4.3 deaths 
per 1,000 births) and the curved dashed lines 
represent the 95% confidence interval around 
the national rate which should include the 
corrected PMR of individual units. Statistically 
one in 20 observations can be expected to be 
outside the 95% confidence range. The corrected 
PMR of all units are within the limits of the 95% 
confidence interval indicating that they are 
consistent with the national rate in 2015.
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Figure 1.4: Funnel plot of the corrected perinatal mortality rate for Irish maternity units, 2015
Figure 1.5: Funnel plot of the stillbirth rate for Irish maternity units, 2015
Note: The error bars illustrate the variation in each unit’s annual corrected PMR since 2011.
In Figure 1.5, the solid horizontal line 
represents the national stillbirth rate of 
4.5 per 1,000. The stillbirth rate of every 
maternity unit was within the limits of the 
95% confidence interval indicating that their 
rate was consistent with the national rate.
Figure 1.4 is a replicate of the funnel plot 
in Figure 1.3, illustrating variation in the 
corrected PMR across Irish maternity units 
in 2014. For each unit, we have added error 
bars to illustrate the range in the unit’s annual 
corrected PMR since 2011 when the NPEC 
perinatal notification form came into use.
The expected greater volatility in the rate 
associated with smaller units is evident. 
The plot also indicates how rarely a unit’s 
corrected PMR falls outside the limits of the 
95% confidence interval or conversely it 
illustrates that the units are consistently in 
line with the national rate.
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Figure 1.6: Funnel plot of the early neonatal mortality rate for Irish maternity units, 2015
In Ireland, women with high risk pregnancies 
may be transferred to the care of tertiary 
maternity units with facilities for specialist 
fetal medicine and high-level neonatal 
intensive care. Data on whether the care of 
the pregnant woman was transferred in utero 
was available for 450 of the 460 perinatal 
deaths in 2015. Of the 450 perinatal deaths in 
2015, there were 36 cases (8.0%) where the 
care of the pregnant woman was transferred 
in utero. 
The 36 in utero transfer cases in 2015 resulted 
in 15 stillbirths (41.7%) and 21 early neonatal 
deaths (58.3%). Twenty six of the 36 in utero 
transfer cases were transferred to one of the 
country’s four large maternity hospitals. For 
these hospitals in 2015, ten percent (n=26, 
10.3%) of their 253 perinatal deaths arose 
from in utero transfer cases. This proportion 
varied across the four hospitals from 8.6% for 
one hospital, 9.2% for another, 11.3% for the 
third hospital and rising to 12.1% for the fourth 
hospital. This shows the impact on perinatal 
mortality rates for these hospitals associated 
with in utero transfer.
The solid horizontal line in Figure 1.7 
represents the national total or uncorrected 
PMR in 2015 (7.0 deaths per 1,000 births) 
and the curved dashed lines represent the 
95% confidence interval around the national 
rate which should include the corrected PMR 
of individual units. Statistically one in 20 
observations can be expected to be outside 
the 95% confidence range. The PMR of one of 
the four large maternity hospitals, at 8.9 per 
1,000 births, is just beyond the upper limit of 
the 95% confidence interval indicating that the 
rate is higher than the national rate in 2015.
In utero transfer
The solid horizontal line in Figure 1.6 represents 
the overall early neonatal mortality rate of 2.5 
per 1,000 live births. None of the maternity 
units had a neonatal mortality rate outside the 
limits of the confidence interval indicating their 
consistency with the national rate.
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In Figure 1.7, the diamonds represent each 
unit’s PMR.  The red squares represent 
each unit’s PMR if there had been no in 
utero transfer cases, i.e. if all mothers who 
experienced perinatal loss after their care had 
been transferred in utero had still experienced 
perinatal loss whilst in the care of the maternity 
unit where she had intended to deliver at the 
time of her first antenatal visit. It is likely that 
most of the country’s small maternity units 
would have had a higher PMR while some, 
particularly the four large maternity hospitals 
would have had a lower PMR. The PMR of 8.9 
of the outstanding maternity hospital would 
have been 9.0% lower at 8.1 per 1,000 births 
and been consistent with the national rate.
Figure 1.7: Funnel plot of the uncorrected perinatal mortality rate (PMR) for Irish maternity 
units, 2015
Note: The blue diamond markers indicate the unit-specific PMR that was observed in 2015 and the red square markers the PMR 
that would have been observed if in utero transfer cases had remained at the unit where the booking appointment had taken place
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The findings presented below are based on 
stillbirths and early neonatal deaths born 
with a birthweight ≥500g and/or gestation at 
delivery ≥24 weeks. 
Age
Data were available for this variable for 454 
of the 460 perinatal deaths in 2015 (98.7%). 
The mothers who experienced perinatal loss 
in 2015 ranged in age from teenage years 
through to late-forties. Their age distribution 
broadly reflected that of the population of 
mothers who gave birth in Ireland (Table 1.4a). 
Over half of the population (54.9%) who gave 
birth in 2015 were aged 25-34 years, whereas 
slightly less of mothers who experienced 
perinatal loss were in this age group (46.9%). 
The age profile of mothers who experienced 
a stillbirth was similar to that of mothers 
who experienced early neonatal death. An 
association between increasing maternal 
age and perinatal mortality was found (Table 
1.4b). For example, mothers aged forty 
years or older had twice the risk (RR=2.09, 
p<0.001) of perinatal mortality compared to 
mothers aged 30-34 years. 
Maternal characteristics
Age group Perinatal deaths Perinatal deaths All births14 Stillbirths Neonatal deaths
(N=465*) (N=454*) (N=291) (N=163*)
2014 2015 2015 2015 2015
<20yrs 11(2.4) 8(1.8) 1.8% 5(1.7) 3(1.8)
20-24yrs 43(9.2) 48(10.6) 8.7% 34(11.7) 14(8.6)
25-29yrs 101(21.7) 83(18.3) 18.8% 51(17.5) 32(19.6)
30-34yrs 142(30.5) 130(28.6) 36.1% 80(27.5) 50(30.7)
35-39yrs 123(26.5) 139(30.6) 28.2% 90(30.9) 49(30.1)
>40yrs 45(9.7) 46(10.1) 6.1% 31(10.7) 15(9.2)
Note: Values are shown as n(%) unless otherwise stated. *Maternal age unknown for six cases in 2015 and six cases in 2014.
Table 1.4a: Age distribution of mothers experiencing perinatal loss in 2015
14 Healthcare Pricing Office (2017) Perinatal Statistics Report 2015. Dublin: Health Service Executive. [in press]
Rate per 1,000  Relative Risk (RR) P-Value
Age group 95% CI 95% CI 
<20yrs 6.7(2.89-13.2) 1.23(0.60-2.5) 0.577
20-24yrs 8.37(6.17-11.1) 1.53(1.10-2.13) 0.012
25-29yrs 6.69(5.33-8.30) 1.22(0.93-1.61) 0.15
30-34yrs 5.47(4.57-6.49) 1.00(reference) -
35-39yrs 7.49(6.30-8.84) 1.37(1.08-1.74) 0.01
>40yrs 11.43(8.37-15.24) 2.09(1.49-2.92) <0.001
Note: Maternal age unknown for six cases in 2015.
Table 1.4b: Comparing the relative risk of perinatal mortality by age group among mothers in 2015
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Occupation
Lower socio-economic status has been 
shown to be associated with poor pregnancy 
outcomes.15 In the NPEC national clinical 
audit, data on the mother’s and father’s 
occupation at booking was sought. Data 
was not recorded for 35 (7.6%) of the 460 
women who experienced perinatal loss, this 
was similar to the proportion of unrecorded 
occupation in 2014 (8.3%). Table 1.6 provides 
a high-level overview of the data that were 
provided on mother’s occupation alongside 
data available for the most comparable 
categories for mothers of all births from the 
Perinatal Statistics Report 201516 and for the 
15-44 year-old female population from the
National Census 2011.
An occupation was specified for 67.8% of the 
425 mothers for whom data were recorded 
(Table 1.6), which is slightly lower than the 
71.1% of all mothers in 2014 with a specified 
occupation. A limitation of both this national 
audit and data from the Perinatal Statistics 
Report is that occupation does not assess 
employment status. It can be seen that 
unemployment status was recorded for 8.0% 
of the mothers experiencing perinatal loss 
compared to 4.5% of all mothers and 10.5% 
of the female population aged 15-44 years. 
The proportion of mothers engaged in home 
duties who experienced perinatal loss (18.4%) 
was slightly less than all women engaged in 
home duties who gave birth (19.9%) in 2015.
Occupation Perinatal deaths All births17 15-44 year-old
n(%) (%) female population
Occupation specified 288(67.8) 72.1 55.0%*
Unemployed 34(8.0) 4.5 10.5%
Home duties 78(18.4) 19.9 12.1%
Student 24(5.6) n/a 19.9%
Others not in labour force 1(0.2) n/a 2.5%
Note: Population data from Census 2011 relates to economic status rather than occupation, hence * represents the proportion 
in employment.
Table 1.6: Occupation at booking of mothers experiencing perinatal loss in 2015
15 Centre for Maternal and Child Enquiries (CMACE) (2010) Perinatal Mortality 2008: United Kingdom. London: CMACE
16 Healthcare Pricing Office. (2017) Perinatal Statistics Report 2015. Dublin: Health Service Executive. [in press]
17 Healthcare Pricing Office. (2017) Perinatal Statistics Report 2015. Dublin: Health Service Executive. [in press]
Ethnicity
Assessment of risk of perinatal loss associated 
with ethnic group is impeded by the absence 
of national data on ethnicity for the pregnant 
population in Ireland. The majority of mothers 
(75.0%) who experienced perinatal loss were 
of white Irish ethnicity. This is close to the 
proportion of white Irish women in the female 
population aged 15-49 years enumerated by 
the National Census 2011. While the numbers 
involved were small, Irish Traveller, Asian and 
Black ethnicities were overrepresented in the 
mothers who experienced perinatal deaths in 
2015 (10.0%) compared to 4.7% of the female 
15-49 year-old population.
Ethnicity Perinatal deaths 15-49 year-old female
2015 population, 2011
White Irish 345(75.0) 80.4%
Irish Traveller 16(3.5) 0.7%
Other white background 49(10.7) 12.5%
Asian/Asian Irish 8(1.7) 2.4%
Black/Black Irish 22(4.8) 1.6%
Other/mixed 14(3) 1.0%
Not recorded/Missing 6(0.7) 1.4%
Note: Values are shown as n(%) unless otherwise stated. Population data from the National Census 2011
Table 1.5: Ethnicity of mothers experiencing perinatal loss in 2015
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Gestation at booking
Gestation at the time of the mother’s first 
antenatal visit to the maternity hospital was 
unrecorded for 45 cases of perinatal death in 
2015 (9.8%). Of those with data, almost one 
in four (24.1%) booked into hospital before 12 
weeks gestation, two-thirds (68.0%) attended 
for antenatal care between 12 and 19 weeks 
gestation (Table 1.7). The proportion of women 
attending for antenatal care at 20 weeks 
gestation or later has decreased from 11.3% in 
2013, to 7.9% in 2014 down to 7.2% in 2015.
Fertility treatment
Currently in Ireland there is no national data 
on the number of births as a result of fertility 
treatment. The NPEC Notification Form contains 
a specific question on whether the pregnancy 
resulting in perinatal loss was the result of fertility 
treatment.  In 2015, information was available for 
423 of the 460 (91.9%) cases of perinatal death. 
In 33 of these cases (7.8%) the pregnancy was 
reported to be the result of fertility treatment 
(n=21 of 269 stillbirths, 7.8 %; n=12 of 154 early 
neonatal deaths, 7.8%). Twenty three of these 
33 pregnancies (69.6%) were associated with 
multiple births ending in perinatal loss of one or 
more infants.
The method of treatment was specified for 29 of 
the 33 (87.9%) pregnancies resulting from fertility 
treatment. In order of frequency, the methods 
were: in vitro fertilisation (n=23), clomid (n=4), 
intracytoplasmic sperm injection (n=1), and 
other (n=1).
Gestation at Perinatal deaths Perinatal deaths Stillbirths Neonatal deaths
booking 2014 2015 2015 2015
Less than 12 Weeks       100(23.8) 100(24.1) 70(25.6) 30(21.1)
12-19 Weeks       279 (66.4) 282(68.0) 183(67.0) 99(69.7)
20 Weeks or Later         33 (7.9) 30(7.2) 18(6.6) 12(8.5)
Not Booked          8 (1.9) 3(0.7) 2(0.7) 1(0.7)
Table 1.7: Weeks gestation at date of first hospital booking in 2015
Note: Values are shown as n(%) unless otherwise stated.
The NPEC Perinatal Death Notification Form 
records the highest level of education 
completed by the mother but this was not 
provided for the vast majority of the 460 
women (359, 78.0%). Level of education is 
not usually captured in maternity records but 
has been found to be associated with poor 
pregnancy outcome.18
18 Savitz, D.A.; Kaufman, J.S.; Dole, N.; Siega-Riz, A.M.; Thorp, J.M., Jr; Kaczor, D.T. Poverty, education, race, and pregnancy 
outcome. Ethn. Dis. 2004, 14, 322–329.
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Body mass index
Increased maternal BMI has been associated 
with an increased risk of congenital anomaly 
and stillbirth.19,20 The recording of BMI in 
maternity records is a key recommendation 
of the Obesity and Pregnancy Clinical Practice 
Guideline. While this may be common practice 
in maternity units, no national data on the BMI 
of the pregnant population are available.21
Body mass index (BMI) was available for 90.4% 
(n=416) of women who experienced perinatal 
loss in 2015. The BMI of 43.8% of these mothers 
was in the healthy range (18.5-24.9kg/m2), 
which is similar to the previous years. In 
each of the five years, 2011-2015, 53.3% of 
the mothers who experienced perinatal loss 
were either overweight or obese albeit with 
fluctuation in the distribution of these two 
groups. The pattern of BMI in the mothers who 
experienced perinatal loss remains similar to 
that in the women from the general population 
who participated in the 2015 Health Ireland 
Survey.22
Table 1.8: Body mass index of mothers who experienced perinatal loss in 2011-2015
BMI Category (kg/m2) Perinatal Perinatal Perinatal Perinatal Perinatal Healthy Ireland
deaths deaths deaths deaths deaths Survey
2011 2012 2013 2014 2015 2015
Underweight (<18.5) 4(1.3) 2(0.6) 6(1.7) 7 (1.7) 5(1.2) 3%
Healthy (18.5-24.9) 140(45.9) 161(46.3) 164(45.6) 183 (45.4) 182(43.8) 44%
Overweight (25.0-29.9) 83(27.2) 116(33.3) 98(27.2) 110 (27.3) 130(31.3) 31%
Obese (>30.0) 78(25.6) 69(19.8) 92(25.6) 103 (25.6) 99(23.8) 22%
Note: Values are shown as n(%) unless otherwise stated; Health Ireland Survey 
Smoking and substance abuse
Smoking status of the mothers at their time 
of booking was recorded for 430 (93.5%) 
of the 460 women. Of these, 87 (20.2%) 
were smokers at the time of booking. Most 
were smoking at least 10 cigarettes per day 
(n=50 of 68, 73.5%; unknown for 19 cases). 
Information on smoking in late pregnancy 
was available for 58 of the 87 smokers 
(66.7%); six (10.3%) stopped smoking during 
pregnancy.
The prevalence of smoking during pregnancy 
or in the last trimester is not routinely known 
for all Irish pregnancies but rates of 12%, 15%, 
16% and 19% have been reported for England, 
Northern Ireland, Wales and Scotland, 
respectively.23
There were two cases with a documented 
history of alcohol abuse and six women had a 
documented history of drug abuse.
19 Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J. Maternal obesity and risk of neural tube defects: a metaanalysis. Am J 
Obstet Gynecol 2008;198:611-9
20 Chu SY, Kim SY, Lau J, Schmid CH, Dietz PM, Callaghan WM, et al. Maternal obesity and risk of stillbirth: a metaanalysis. Am J 
Obstet Gynecol 2007;197:223-8.
21 Clinical Practice Guideline No 2 (2011). Obesity and Pregnancy: Institute of Obstetricians and Gynaecologists, Royal College 
of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive.
22 Ipsos MRBI (2015).Healthy Ireland Survey 2015. Dublin: The Stationery Office.
23 EURO-PERISTAT Project with SCPE and EUROCAT. European Perinatal Health Report. The health and care of pregnant women 
and babies in Europe in 2010. May 2013. Available www.europeristat.com
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Previous pregnancy
Seventy percent of mothers who experienced 
perinatal loss in 2015 had at least one previous 
pregnancy (gravida > 0) (324 of 460, 70.4%). 
Table 1.9 specifies gravida/parity for the 460 
women who experienced perinatal loss in 
2015. Nearly thirty percent (n=136, 29.6%) 
had never been pregnant before (gravida = 
0). Of the 324 women who had been pregnant 
(gravida > 0), most (n=167, 51.5%) had 
pregnancies exceeding 24 weeks or 500g 
birthweight (gravida = parity, indicated by 
green shading); 36.1%(n=117) experienced 
at least one pregnancy exceeding 24 weeks or 
500g birthweight and at least one pregnancy 
less than 24 weeks gestation and under 500g 
birthweight (gravida > parity > 0, indicated by 
yellow shading); and, for 12.3% (n=40) their 
previous pregnancies never exceeded 24 
weeks gestation or 500g birthweight (gravida 
> parity = 0, indicated by orange shading).
Of the 324 women who had a previous 
pregnancy, 43.8% (n=142) were reported 
to have had a previous pregnancy-related 
problem. Caesarean section delivery was the 
most common previous pregnancy-related 
problem with over one in five (n=71, 21.9%) 
mothers having a previous caesarean section 
delivery (Table 1.10). Pre-term birth or mid-
trimester loss was the second most common, 
with (n=25, 7.7%) of mothers experiencing pre-
term birth or mid-trimester loss in a previous 
pregnancy. Three or more miscarriages 
(n=24, 7.4%) was the third most common 
pregnancy-related problem in mothers who 
had a previous pregnancy.
Table 1.9: Gravida/parity of mothers prior to experiencing perinatal loss in 2015 
Note: We refer to gravida and parity prior to the pregnancy ending in perinatal death in 2015. Green represents women with 
previous pregnancies only of ≥24 weeks or ≥500g; yellow represents women who had experienced pregnancy ≥24 weeks 
or ≥500g and pregnancy <24 weeks and <500g; and, orange represents women whose previous pregnancies were always 
<24 weeks gestation and <500g birthweight.
Gr
av
id
a
Parity 
0 1 2 3 4 5 6 7 Total
0 136 0 0 0 0 0 0 0 136
1 28 96 0 0 0 0 0 0 124
2 6 38 48 0 0 0 0 0 92
3 1 5 21 12 0 0 0 0 39
4 1 5 10 10 5 0 0 0 31
5 2 3 2 4 3 3 0 0 17
6 1 2 2 1 1 4 2 0 13
7 0 0 1 0 0 0 1 1 3
8 1 0 0 0 0 0 2 0 3
9 0 0 0 1 0 0 0 0 1
10 0 0 0 0 0 1 0 0 1
Total 176 149 84 28 9 8 5 1 460
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In terms of parity, women who experienced 
perinatal loss in 2015 were similar to the 
population of women who gave birth in 2015 
(Table 1.11).  
Table 1.10: Previous pregnancy-related problems in mothers who experienced perinatal loss in 2011-2015
2011 2012 2103 2014 2015
n(%) n(%) n(%) n(%) n(%)
Previous caesarean delivery 55(18.9) 60(19.9) 61(18.7) 63(18.9) 71(21.9)
Pre-term birth or mid-trimester loss 18(6.2) 19(6.3) 13(4.0) 29(8.7) 25(7.7)
Three or more miscarriages 11(3.8) 13(4.3) 14(4.3) 16(4.8) 24(7.4)
Infant requiring intensive care 7(2.4) 3(1.0) 5(1.5) 14(4.2) 13(4)
Stillbirth 7(2.4) 9(3.0) 10(3.1) 7(2.1) 12(3.7)
Baby with congenital anomaly 8(2.7) 6(2.0) 4(1.2) 7(2.1) 10(3.1)
Pre-eclampsia 19(6.5) 13(4.3) 14(4.3) 18(5.4) 8(2.5)
Post-partum haemorrhage requiring transfusion 5(1.7) 6(2.0) 3(0.9) 4(1.2) 5(1.5)
Placental abruption 2(0.7) 4(1.3) 1(0.3) 4(1.2) 4(1.2)
Neonatal death 5(1.7) 11(3.7) 9(2.8) 6(1.8) 3(0.9)
Placenta praevia 1(0.3) 1(0.3) 1(0.3) 2(0.6) 1(0.3)
Other 68(23.4) 54(17.9) 39(12.0) 47(14.1) 35(10.8)
Note: Percentage of mothers who had a previous pregnancy
Note: Values are shown as n(%) unless otherwise stated.
Parity Perinatal Perinatal Perinatal Perinatal Perinatal All births24
deaths deaths  deaths deaths deaths 2015
2011 2012 2013 2014 2015
Nulliparous 205(45.5) 186(41.8) 174(37.6) 182 (38.7) 176(38.3) 38.3%
Para 1 122(27.1) 129(29.0) 137(29.6) 142 (30.2) 149(32.4) 34.8%
Para 2 71(15.7) 72(16.2) 87(18.8) 85 (18.1) 84(18.3) 17.7%
Para 3+ 53(11.7) 58(13.0) 65(14.0) 61 (13.0) 51(11.1) 9.2%
Table 1.11: Distribution of parity, 2011-2015
24 Healthcare Pricing Office. (2017) Perinatal Statistics Report 2015. Dublin: Health Service Executive. [in press]
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Pre-existing medical problems
Information about pre-existing medical 
conditions was available for 446 of the 460 
mothers who experienced perinatal loss 
(97.0%). Over thirty percent of these 446 
women had a pre-existing medical problem 
(n=139, 31.2%). This is lower than the 40.0% 
rate in 2014 and 33.2% rate in 2013. There 
were no highly prevalent conditions and 
no notable changes in the prevalence of 
specific problems from 2011 to 2015 (Table 
1.12). The Other category included a wide 
range of problems such as asthma, anaemia, 
infertility and urinary tract infection
2011 2012 2013 2014 2015
n(%) n(%) n(%) n(%) n(%)
Psychiatric disorder 23(5.7) 19(4.5) 25(5.7) 34(7.6) 32(7.2)
Endocrine disorder 19(4.7) 21(5.0) 17(3.9) 30(6.7) 24(5.4)
Diabetes 7(1.7) 8(1.9) 13(3.0) 16(3.6) 16(3.6)
Hypertension 12(3.0) 22(5.2) 7(1.6) 10(2.2) 13(2.9)
Cardiac disease 8(2.0) 6(1.4) 11(2.5) 9(2) 6(1.3)
Haematological disorder 7(1.7) 6(1.4) 3(0.7) 8(1.8) 5(1.1)
Renal disease 7(1.7) 9(2.1) 6(1.4) 7(1.6) 4(0.9)
Inflammatory disorder 7(1.7) 7(1.7) 3(0.7) 6(1.3) 17(3.8)
Epilepsy 7(1.7) 5(1.2) 4(0.9) 1(0.2) 5(1.1)
Other 126(31.3) 103(24.3) 92(20.9) 107(23.9) 65(14.6)
Any pre-existing medical problem 179(44.5) 169(40.0) 146(33.2) 179(40.0) 139(31.2)
Table 1.12: Pre-existing medical problems in mothers who experienced perinatal loss in 2011-2015
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Table 1.13: Mode of delivery for mothers who experienced perinatal loss in 2015
Stillbirths Neonatal deaths All births25  
(N=294) (N=166) 
Spontaneous Vaginal Cephalic 174(59.2) 69(41.6) 
53.6%
Spontaneous Vaginal Breech 19(6.5) 2(1.2) 
Pre-labour Caesarean Section 42(14.3) 57(34.3) 
31.3%
Caesarean Section 10(3.4) 21(12.7) 
Assisted breech 46(15.6) 15(9.0) 0.4%
Ventouse 2(0.7) 0(0) 11.2%
Forceps 1(0.3) 2(1.2) 3.5%
Note: Values are n(%) unless otherwise stated.
Emergency caesarean section delivery 
was the most common type of caesarean 
section delivery, accounting for 38.5% of 
the 130 cases of perinatal death delivered 
by caesarean section (n=45 of 117, 
unknown for 13 cases), over one third were 
categorised as urgent (n=41 of 117, 35.0%) 
and over one quarter were elective (n=31 
of 117, 26.5%). Elective caesarean delivery 
was the most common type of caesarean 
delivery in stillbirths (n=20 of 46, 43.5%, 
unknown for six cases) and emergency 
caesarean delivery was the most common 
type of caesarean delivery in early neonatal 
deaths (n=30 of 71, 42.3%, unknown for 
seven cases). 
25 Healthcare Pricing Office.(2017) Perinatal Statistics Report 2015. Dublin: Health Service Executive. [in press]
Delivery
Labour was induced in 63.9% of women 
who experienced a stillbirth (n=184 of 288, 
unknown for six cases) and 17.5% of those 
who experienced a neonatal death (n=29 of 
166). A caesarean section was the planned 
mode of delivery for 11.5% of the women 
who experienced a stillbirth (n=33 of 287; 
unknown for seven cases) and 19.5% of the 
women who experienced an early neonatal 
death (n= 32 of 164; unknown for two cases).
The type of care received at delivery was known 
for almost all of mothers who experienced 
perinatal loss (99.1% n=456 of 460). 
Approximately 95.8% of the babies (n=437 of 
456) were delivered under obstetric-led care
which is the predominant model of care in
Ireland. Twelve babies (2.6%) were delivered
under midwifery-led care, six babies (1.3%)
were born before arrival at the maternity unit
and one baby was delivered under the care of
a self-employed community midwife.
Presentation at delivery was known for 95.2% 
(n=438 of 460) of mothers who experienced 
perinatal loss. Nearly three quarters of 
presentations at delivery were vertex 
presentations (n=321 of 438, 73.3%), almost 
one in five were breech presentation (n=106 of 
438, 24.2%) and in eleven cases, the presentation 
was either compound (n=10) or face (n=1).
Mode of delivery was known for all mothers 
who experienced perinatal loss. Spontaneous 
vaginal cephalic delivery was the mode of 
delivery for approximately sixty percent of 
stillbirths (n=174 of 294, 59.2%) and for over 
forty percent of the babies who died in the 
early neonatal period (n=69 of 166, 41.6%) 
(Table 1.13). Over forty percent (46.9%) of the 
deliveries in cases of neonatal death involved 
caesarean section, usually pre-labour (34.3%). 
Almost twenty percent of stillbirths involved 
caesarean section, again predominantly pre-
labour (14.3%). Among stillbirths delivered 
by caesarean section, over forty percent of 
the mothers (n=23 of 52, 44.2%) had had a 
previous caesarean delivery. Assisted breech 
deliveries were relatively more common in 
cases of stillbirth (15.6%) and neonatal death 
(9.0%) whereas this was a very rare mode 
delivery for all births in 2015 (0.4%). 
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Level of care for mothers post-delivery
For women who experienced perinatal loss in 
2015, 9.1% (n=41) were admitted to a high 
dependency unit (HDU) and 2.0% (n=9) were 
admitted to an intensive care unit (ICU). Similar 
admission rates were reported for 2011, 2012, 
2013 and 2014 (Table 1.14). Admission to both 
the HDU and ICU for the mother was more 
common in cases of early neonatal death than 
stillbirth. Deliveries by emergency caesarean 
section were associated with higher levels 
of admission to both the HDU (n=12 of 44, 
27.3%) and ICU (n=5 of 44, 11.4%).
Infant characteristics
The findings presented below are based on 
stillbirths and early neonatal deaths born 
with a birthweight ≥500g and/or gestation at 
delivery ≥24 weeks.
Sex
The sex of the baby was not reported for seven 
cases, of the 453 perinatal deaths where sex 
was reported, 52.3% were male (n=237). 
In the overall population of births in 2015, 
51.1% were male.26 There were four perinatal 
deaths for which the sex of the baby was 
indeterminate (Table 1.15).
Multiple births
There was an association between perinatal death 
and multiple pregnancies. There were 68 perinatal 
deaths from multiple births, making up 14.8% of 
all perinatal deaths in 2015. This is 3.9 times the 
proportion of multiples among all births in 2015 
(3.8%).26 
The 68 perinatal deaths from multiple births 
comprised 40 stillbirths and 28 early neonatal 
deaths. Most (n=15, 53.6%) of the 28 early neonatal 
deaths from multiple births were due to respiratory 
disorders, most often severe pulmonary 
immaturity, the remaining 13 deaths were due 
to major congenital anomalies (n=8, 28.6%), 
unexplained (n=3, 1.7%), neurological (n=1, 3.6%) 
and infection (n=1, 3.6%). The main causes of the 
40 stillbirths from multiple births were specific fetal 
conditions (n=11, 27.5%) all of which were due to 
twin-twin transfusion, major congenital anomalies 
(n=9, 22.5%), placental conditions (n=6, 15.0%), 
intra-uterine growth restriction (n=5, 12.5%) and 
infection (n=4, 10.0%), while the main cause was 
unexplained for five cases (12.5%).
Perinatal Perinatal Perinatal Perinatal  Perinatal Stillbirths Neonatal
deaths deaths deaths deaths deaths deaths
2011 2012 2013 2014 2015 2015 2015
Admitted to HDU 27(5.9) 29(6.5) 29(6.4) 25(5.4) 41(9.1) 19(6.6) 22(13.4)
Admitted to ICU 8(1.8) 7(1.6) 6(1.3) 16(3.4) 9(2.0) 5(1.7) 4(2.4)
Stillbirths Early neonatal deaths
n(%) n(%)
Male 139(48.4) 98(59.0)
Female 145(50.5) 67(40.4)
Indeterminate 3(1.0) 1(0.6)
 Table 1.14: Post-delivery outcome for mothers who experienced perinatal loss in 2011-2015
Table 1.15: Sex of baby in stillbirths and neonatal deaths in 2015
26 Healthcare Pricing Office. (2017) Perinatal Statistics Report 2015. Dublin: Health Service Executive. [in press]
Note: Values are n(%) unless otherwise stated. Admission data unknown for nine women in 2015.
Note: Sex was not reported for seven cases of stillbirth.
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Gestation
Almost seventy percent of perinatal deaths in 
2015 were associated with delivery before 37 
weeks gestation (n=315 of 460, 68.5%). This 
was the case for 70.1% of stillbirths (n=206 
of 294) and 65.7% of early neonatal deaths 
(n=109 of 166). Extremely pre-term delivery, 
i.e. delivery at 22-27 weeks gestation, was
more often associated with cases of early
neonatal death than cases of stillbirth (Figure
1.8).
22.4
27.1
29.3
33.7
17.0
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Figure 1.8: Distribution of gestational age at delivery in stillbirths and neonatal deaths in 2015
Chorionicity was reported for 62 of the 68 perinatal 
deaths from multiple births. There were more cases 
that were dichorionic diamniotic (n=34, 54.8%) 
compared to monochorionic diamniotic (n=25, 
40.3%). The observed proportion of monochorionic 
diamniotic twins is higher than would be expected 
based on all twin deliveries in Ireland.
There were 44 cases where one twin died, nine 
cases where both twins died, two cases where one 
triplet died and two cases where two triplets died, 
indicating a total of 68 perinatal losses involving 
57 pregnancies. It was reported that 23 of these 
pregnancies were the result of fertility treatment 
(23 of 49 pregnancies, 46.9%, unknown for eight 
pregnancies).
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27 Gardosi J, Francis A. Customised Weight Centile Calculator. GROW version 6.7.6.5(IE), 2015 Gestation Network, 
www.gestation.net
28 Unterscheider J, Geary MP, Daly S, McAuliffe FM, Kennelly MM, Dornan J, Morrison JJ, Burke G, Francis A, Gardosi J, Malone 
FD. The customized fetal growth potential: a standard for Ireland. Eur J Obstet Gynecol Reprod Biol 2013; 166(1):14-7
Birthweight centile
An increased risk of perinatal death has been 
associated with failure of fetal growth in utero. We 
have produced two charts to highlight this issue 
in relation to the stillbirths and early neonatal 
deaths that occurred in Ireland in 2015. To do so, 
we used the Gestation Related Optimal Weight 
(GROW) software27 and coefficients derived from 
the multiple regression analysis of data on 11,072 
births in six maternity units in Dublin, Galway, 
Limerick and Belfast in 2008-2009. 28
The regression analysis determined the Term 
(i.e. 40 weeks) Optimal Weight (TOW) in Ireland 
to be 3,490.7g. The normal range (i.e. the range 
from the 10th centile weight to the 90th centile 
weight) around the TOW was then calculated 
and the recommended proportionality growth 
function was applied to the TOW, the 10th centile 
term weight and the 90th centile term weight in 
order to determine the optimal weight and normal 
range at all gestations (21-44 weeks for stillbirths 
and early neonatal deaths in Ireland in 2015). 
These steps are described in detail in the GROW 
documentation.
The optimal weight and normal range for all 
gestations are plotted with the actual birthweights 
of the stillbirths in Figure 1.10 and with the 
birthweights for cases of early neonatal death in 
Figure 1.11. For stillbirths, it can be seen that a 
high proportion were below the lower limit of the 
normal range (10th centile). In cases of early 
Birthweight
The most represented birthweight in cases 
of perinatal death was in the range 500-999 
grams (n=119 of 459, 25.9%; birthweight 
unknown for one case). This was more so for 
early neonatal deaths than stillbirths (Figure 
1.9). For almost seventy percent of perinatal 
deaths (n=316, 68.8%; n=206, 70.3% of 
stillbirths; n=110, 66.3% of neonatal deaths) 
the birthweight was less than 2,500 grams.
10.910.6
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Figure 1.9: Distribution of birthweight in stillbirths and neonatal deaths in 2015
Note: Birthweight unknown for one case in 2015.
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Figure 1.11: Optimal birthweight and normal range compared to actual birthweights in early neonatal deaths, 2015
29 Clausson B, Gardosi J, Francis A, Cnattingius S. Perinatal outcome in SGA births defined by customised versus population–
based birthweight standards. BJOG 2001;108:830–4.
30 Royal College of Obstetrics and Gynaecologists. The investigation and management of the small-for-gestational age fetus. 
RCOG Green Top Guideline 2013 (NO.31). Available at: www.rcog.org.uk/files/rcog-corp/22.3.13GTG31SGA_ExecSum.pdf
neonatal death, the birthweight was often below 
the normal range, particularly for births after 33 
weeks gestation. However, low birthweight was 
observed less often than for cases of stillbirth.
Figures 1.10 and 1.11 have the limitation of 
plotting actual birthweights against the optimal 
weight and normal range adjusted only for 
gestational age. There is no adjustment for other 
factors affecting birthweight, namely, maternal 
height, weight, parity and ethnic group and infant 
sex. The use of centiles customised for maternal 
and infant characteristics affecting birthweight 
identifies small babies at higher risk of mortality 
better than population centiles.29 Small-for-
gestational-age (SGA) refers to birthweights 
below the 10th centile and severely SGA refers to 
birthweights less than the 3rd centile.30
Figure 1.10: Optimal birthweight and normal range compared to actual birthweights of stillbirths, 2015
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Figure 1.12: Distribution of customised birthweight centiles for stillbirths, 2015
Figure 1.13: Distribution of customised birthweight centiles for early neonatal deaths, 2015
Customised birthweight centiles were derived 
using the GROW software.31 There was missing 
data for maternal height and weight with one or 
both unknown for 10.0% of the mothers (n=46). 
For these cases, we used the median height 
and weight of the mothers with complete data. 
The GROW software also provides estimated 
customised birthweight centiles in cases 
with missing data. Ultimately, customised 
birthweight centiles were calculated for 459 of 
the 460 mothers (99.8%).
The distribution of customised birthweight 
centiles at all gestations is illustrated for 
stillbirths in Figure 1.12 and for early neonatal 
deaths in Figure 1.13. At all gestations, 
there were cases spanning the full range of 
birthweight centiles (i.e. 0-100th) but there 
was a clear overrepresentation of cases below 
the median and far more at or near centile zero 
than would be expected in the population of all 
births.
31 Gardosi J, Francis A. Customised Weight Centile Calculator. GROW version 6.7.6.5(IE), 2015 Gestation Network, www.gestation.net
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Centile Stillbirth (N=293 of 294) Neonatal death (N=166)
Cause of death: Cause of death:
major congenital anomaly major congenital anomaly
Yes(n=79) No(n=214) Yes(n=98) No(n=68)
< 3rd 50(63.3%) 62(29.0%) 47(48.0%) 9(13.2%)
< 10th 56(70.9%) 103(48.1%) 60(61.2%) 15(22.1%)
10-49th 14(17.7%) 70(32.7%) 20(20.4%) 25(36.8%)
50-89th 4(5.1%) 31(14.5%) 10(10.2%) 20(29.4%)
90th+ 5(6.3%) 10(4.7%) 8(8.2%) 8(11.8%)
Note: Centiles could not be calculated for one stillbirth case. 
Table 1.17: Distribution of customised birthweight centiles of perinatal deaths due and not due to major 
congenital anomaly, 2015
Cases of stillbirth and early neonatal death 
were at significantly lower birthweight centiles 
when the cause of death was attributed 
to major congenital anomaly (Table 1.17). 
Most of the 79 stillbirths due to congenital 
anomaly (n=50, 63.3%) were severely SGA 
in comparison to nearly thirty percent of 
the stillbirths due to other causes (n=62, 
29.0%). Similarly, almost half of the 98 early 
neonatal deaths due to congenital anomaly 
(n=47, 48.0%) were severely SGA compared to 
thirteen percent (n=9, 13.2%) of the 68 early 
neonatal deaths due to other causes.
Table 1.16 details the number and percentage 
of stillbirths and early neonatal deaths within 
specific ranges of customised birthweight 
centiles. Low birthweight was associated with 
both groups but particularly with stillbirths: 
almost thirty percent of stillbirths had a 
birthweight at centile zero (29.4%) compared to 
22.9% of early neonatal death cases. Thirty eight 
percent of stillbirths (38.2%) were classified 
as severely SGA (<3rd customised birthweight 
centile) and fifty four percent (54.3%) were 
SGA (<10th customised birthweight centile) 
compared to 33.7% and 45.2% of the cases of 
early neonatal death, respectively. SGA may be 
more prevalent among stillborn babies because 
they may have died some days or weeks before 
being delivered. We do not record whether there 
was evidence of maceration in cases of stillbirth 
but there was support for this hypothesis. The 
data showed a correlation whereby the longer the 
time between confirmation of death and time of 
delivery, the lower the customised birthweight 
centile of the stillborn baby.
Centile Stillbirth n(%) Neonatal death n(%)
(N=293 of 294) (N=166)
< 3rd 112(38.2) 56(33.7)
< 10th 159(54.3) 75(45.2)
10-49th 84(28.7) 45(27.1)
50-89th 35(11.9) 30(18.1)
Note: Centiles could not be calculated for one stillbirth.
Table 1.16: Distribution of customised birthweight centiles, 2015
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The NPEC Perinatal Death Notification Form 
2015 (Appendix E) contains a specific 
question on whether a diagnosis of IUGR 
was made in perinatal deaths and the timing 
of diagnosis if applicable. A diagnosis of 
IUGR was reported for 81 (18.0%) of the 449 
perinatal deaths (unknown for 11 cases), 
21.1% of stillbirths (n=60) and 12.8% of early 
neonatal deaths (n=21). In most diagnosed 
cases, IUGR was suspected antenatally (Table 
1.18). The majority of cases with a diagnosis 
of IUGR (n=70 of 81, 86.4%) were severely SGA 
(<3rd customised birthweight centile). Major 
congenital anomaly was the main cause of 
death in almost fifty percent of the cases with 
a diagnosis of IUGR (n=39, 48.1%); placental 
conditions were the main or associated cause 
of death in nearly thirty percent of cases 
(n=23, 28.4%); and IUGR was the main or 
associated cause of death for eight cases 
(9.9%).
Among the 430 mothers whose smoking 
status was known at the time of their 
hospital booking, data on IUGR diagnosis 
was recorded for 426 of these 430 mothers 
(IUGR diagnosis unknown for four cases). 
The prevalence of a diagnosis of IUGR was 
slightly higher in the infants of smokers 
(n=18 of 86, 20.9%) compared to infants 
of non-smokers (n=68 of 340, 20.0%). A 
diagnosis of IUGR was relatively common 
among mothers with a pregnancy-related 
hypertensive disorder (n=11 of 27, 40.7% 
versus n=70 of 422 mothers without 
pregnancy-related hypertension, 16.6%).
Stillbirth n(%) Neonatal death n(%)
(N=60) (N=21)
Suspected antenatally 37(61.7) 19(90.5)
Observed at delivery 33(55) 9(42.9)
Observed at post-mortem 28(46.7) 3(14.3)
Note: Categories are not mutually exclusive and may add up to more than 100%
Table 1.18: Diagnosis of intra-uterine growth restriction in 2015
Diagnosis of intra-uterine growth restriction (IUGR)
Investigations to determine the cause of death
Autopsy
Current practice guidelines32 recommend that 
parents should be offered a full post-mortem 
examination of the stillborn infant to help 
explain the cause of death. Data on autopsy 
uptake was reported for 452 of the 460 perinatal 
deaths, of which 50.4% (n=228) underwent 
an autopsy. The proportion of autopsy uptake 
in 2015 was slightly higher than the 48.3% 
reported in 2014 and the 45.4% reported in 
2013. The trend in the perinatal autopsy rate is 
illustrated in Figure 1.14. The autopsy uptake 
rate has been higher for stillbirths than in cases 
of early neonatal death, albeit by a smaller 
margin in recent years.
In Ireland in 2015, an autopsy was undertaken 
following 55.3% of stillbirths (n=162 of 293, 
unknown for one case) and 41.5% of early 
neonatal deaths (n=66 of 159, unknown for 
seven cases). These figures are higher than 
in the UK as a whole in 2014 (full autopsy 
for 43.5% of stillbirths and 27.1% of early 
neonatal deaths)33, whereas the autopsy rate 
in Northern Ireland in 2014 was higher for 
stillbirths (63.7%) and slightly lower for early 
neonatal deaths (37.0%).34
32 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute of Obstetricians and 
Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, Health Service Executive.
33 Manktelow BM, Smith LK, Evans TA, Hyman-Taylor P, Kurinczuk JJ, Field DJ, Smith PW, Draper ES, on behalf of the MBRRACE-UK collaboration. Perinatal 
Mortality Surveillance Report UK Perinatal Deaths for births from January to December 2014. Leicester: The Infant Mortality and Morbidity Group, Department 
of Health Sciences, University of Leicester. 2016.
34 Northern Ireland Maternal and Child Health. Perinatal mortality: Northern Ireland 2014. In Press. Belfast: Northern Ireland Public Health Agency.
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There was signifi cant variation in the rate of 
autopsy across the 19 maternity units in 2015 
as illustrated in the funnel plot (Figure 1.15). 
This may refl ect variation in access to dedicated 
perinatal pathology services across units. There 
was some variation found across the four large 
maternity units, with rates of 41%, 48%, 59% and 
69% being found across the four units.
Figure 1.14: Autopsy uptake percentage, 2011-2015
Figure 1.15: Funnel plot of autopsy uptake in the 19 Irish maternity units in 2015
Note: Autopsy unknown for one case of stillbirth and seven cases of early neonatal death.
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Figure 1.16 details the autopsy-related steps 
taken following 452 of the 460 perinatal deaths 
in 2015 (unknown for eight cases). Forty-six 
of the deaths became coroner cases (10.2%, 
unknown for 11 cases). These cases underwent 
autopsy and at the time data were reported to 
the NPEC, the maternity unit had received the 
autopsy report from the coroner’s office in 34 of 
the 46 cases (79.1%, unknown for three cases). 
Data on whether an autopsy was performed was 
recorded for 397 of the 403 perinatal deaths that 
did not became coroner cases. There were 177 
autopsies undertaken following the 397 deaths 
that were not coroner cases, an autopsy rate of 
44.6% (n=142, 52.6% for stillbirths and n=35, 
27.6% for early neonatal deaths).
There were 224 perinatal deaths that did not 
receive an autopsy. For the majority of these 
cases an autopsy was offered and presumably 
declined by parents (n=178, 84.0%, it was 
unknown if autopsy was offered for 12 cases). 
This is a slight increase in the rate of autopsy 
offer reported in 2014 (80.8%). Such an offer 
was made more often in cases of stillbirth (110 
of 127, 86.6%, unknown for four cases) than for 
early neonatal deaths (68 of 93, 80.0%, unknown 
for eight cases). Consequently, in 2015 of the 
452 cases were data on autopsy uptake was 
reported, there were 34 perinatal deaths for 
which an autopsy was not offered (n=34 of 452, 
7.5%, autopsy uptake unknown for eight cases). 
This represents a slightly lower proportion than 
in 2014, when 43 of perinatal deaths were not 
offered an autopsy (n=43 of 458, 9.4%, autopsy 
uptake unknown for 13 cases).
Figure 1.16: Flowchart describing autopsy-related steps taken after 460 perinatal deaths in 2015
Note: *Autopsy unknown for one case of stillbirth and seven cases of early neonatal death. **Autopsy offer was 
unknown for four cases of stillbirth and eight cases of early neonatal death that did not undergo an autopsy. 
SB= Stillbirth ENND= Early neonatal death
The decision not to offer to undertake an 
autopsy may be influenced by the clinical 
scenario and the antenatal diagnosis. There 
was evidence to support this in relation to 
major congenital anomaly. The proportion of 
cases not offered an autopsy was higher if the 
perinatal death was due to a major congenital 
anomaly than if it the death was due to 
another cause (Table 1.19).
 41
Autopsy Stillbirth (N=289 of 294) Neonatal death (N=151 of 166)
Cause of death:  Cause of death: 
major congenital anomaly major congenital anomaly
Yes (n=76) No (n=213) Yes (n=88) No (n=63)
Performed 25(32.9%) 137(64.3%) 36(40.9%) 30(47.6%)
Offered 43(56.6%) 67(31.5%) 40(45.5%) 28(44.4%)
Not offered 8(10.5%) 9(4.2%) 12(13.6%) 5(7.9%)
Note: Data on whether autopsy was performed and/or offered was incomplete for five cases of stillbirth and 15 cases of early neonatal death.
Table 1.19: Uptake and offer of autopsy of perinatal deaths due and not due to major congenital anomaly, 2015
Placental examination 
The value of placental examination in 
determining cause of perinatal death is well 
documented.35 In 2015, placental histology 
examinations were conducted for almost all 
stillbirths (n=289 of 292 stillbirths, 99.0%, 
unknown for two cases) and for 92.0 % of early 
neonatal deaths (n=150 of 163 of stillbirths, 
unknown for three cases). Thus, there has 
been an increase in the rate of placental 
histology examination for stillbirths from 
94.8% in 2014 to 99.0% in 2015 and for early 
neonatal deaths from 79.4% in 2014 to 92.0% 
in 2015. In 2014, lower levels of placental 
histology examinations were reported for 
stillbirths (91.2%) and early neonatal deaths 
(73.8%) in Northern Ireland36 and also for 
stillbirths in the UK as a whole (88.4%).37
Abnormal placental findings have been 
classified and are presented under the 
following broad categories: maternal vascular 
malperfusion, fetal vascular malperfusion, 
cord pathology, delayed villous maturation 
defect, chorioamnionitis, villitis and other. 
This is in keeping with recommendations in 
a recent publication from an international 
consensus meeting of pathology.38
Of the 294 stillbirths and 166 early neonatal 
deaths for which placental examinations were 
conducted, specific placental conditions in 
at least one of the above categories were 
reported in 189 (64.3%) of stillbirths and 
71 (42.8%) of early neonatal deaths (Table 
1.20).  More than one placental condition was 
present for some cases. 
Specific placental conditions were generally 
more prevalent among stillbirths than 
among cases of early neonatal death with 
the exception of chorioamnionitis which was 
reported in approximately twelve percent of 
early neonatal deaths (n=20, 12.0%) and nine 
percent of stillbirths (n=26, 8.8%). In the case 
of stillbirths, conditions within the maternal 
vascular malperfusion category were most 
commonly reported (n=72, 24.5%).
Submission of anonymised placental 
histology reports to the NPEC as part of 
this audit would facilitate standardised 
interpretation and classification of placental 
conditions at national level.
Specific placental conditions
35 Korteweg FJ, Erwich JJ, Timmer A, van der Meer J, Ravise JM, Veeger NJ, Holm JP. Evaluation of 1025 fetal deaths: proposed 
diagnostic workup. Am J Obstet Gynecol 2012 206:53.e1-53.e12
36 Northern Ireland Maternal and Child Health. (2016) Perinatal mortality: Northern Ireland 2014. Belfast: Northern Ireland Public 
Health Agency.
37 Manktelow BM, Smith LK, Evans TA, Hyman-Taylor P, Kurinczuk JJ, Field DJ, Smith PW, Draper ES, on behalf of the MBRRACE-UK 
collaboration. Perinatal Mortality Surveillance Report UK Perinatal Deaths for births from January to December 2014. Leicester: The 
Infant Mortality and Morbidity Group, Department of Health Sciences, University of Leicester. 2016.
38 Khong TY, Mooney EE et al (2016). Sampling and definition of placental lesions. Arch Pathol Lab Med 2016 Jul;140 (7):698-713
42  PERINATAL MORTALIT Y IN IREL AND ANNUAL REPORT 2015 
Stillbirth n(%) Neonatal death n(%)
(N=294) (N=166)
Maternal vascular malperfusion 72(24.5) 22(13.3)
Fetal vascular malperfusion 51(17.3) 16(9.6)
Cord pathology 50(17.0) 10(6.0)
Delayed villous maturation 20(6.8) 7(4.2)
Chorioamnionitis 26(8.8) 20(12.0)
Villitis 11(3.7) 4(2.4)
Other 44(15.0) 27(16.3)
Any placental condition 189(64.3) 71(42.8)
Note: More than one placental condition was present for some cases.
Table 1.20: Placental histology findings for stillbirths and early neonatal deaths, 2015
External examinations was performed for 
forty eight percent of the 460 perinatal deaths 
in 2015 (n=219, 47.8%) compared to forty five 
percent (54.0%) in 2014 (Table 1.21). X-Ray 
was reported to have been performed slightly 
more often following perinatal death in 2015 
(33.6%) than in 2014 (31.3%). Computerised 
tomography scans and magnetic resonance 
imaging tests were rarely undertaken. 
External examination and X-ray were carried 
out more often following cases of stillbirth in 
2015 than for cases of early neonatal death. 
Cytogenetic analysis is an important 
investigation in the diagnosis of chromosomal 
abnormalities. Some abnormalities are 
potentially recurrent and can be tested for 
in future pregnancies.39 In the event of a 
chromosomal disorder, a specific question 
on the NPEC Perinatal Death Notification 
form (Appendix E) asks how the diagnosis 
was made. A major congenital chromosomal 
disorder was the main cause in 69 perinatal 
deaths in 2015 (52 stillbirths and 17 early 
neonatal deaths). For fifty eight percent of 
these cases (n=40, 57.8%), the diagnosis 
was made by cytogenetic analysis (n=30 
stillbirths, 57.7%; n=10 neonatal deaths, 
58.8%). 
Other examinations performed
Genetic investigation in chromosomal disorders
Note: CT=Computerised tomography, MRI=Magnetic resonance imaging. Data on whether other examinations were performed were missing for two cases 
of early neonatal death. 
Table 1.21: Other examinations performed in investigating perinatal deaths, 2012 to 2015
Examination Perinatal Perinatal Perinatal  Perinatal Stillbirths Neonatal
deaths deaths deaths deaths deaths
2012 2013 2014 2015 2015 2015
External 170 (38.2) 247 (53.3) 211 (45.0) 219 (47.8) 146 (49.7) 73 (44.5)
X-Ray 63 (14.2) 118 (25.5) 147 (31.3) 154 (33.6) 114 (38.8) 40 (24.4)
CT scan 2 (0.4) 7 (1.5) 1 (0.2) 0 1 (0.3) 0
MRI 4 (0.9) 0 (0.0) 2 (0.4) 1 (0.2) 1 (0.3) 0
39 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: Institute 
of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical Programmes, 
Health Service Executive.
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Congenital anomalies and mortality
Congenital anomalies can be defined as structural 
or functional anomalies (metabolic disorders) 
that occur during intrauterine life and can be 
identified prenatally, at birth, or sometimes may 
only be detected later in infancy, such as hearing 
defects. They are responsible for 303,000 deaths 
worldwide per annum (WHO, 2016). Congenital 
anomalies can contribute to long-term disability, 
the most common being severe heart defects, 
neural tube defects and Down syndrome. In 
more than half of cases the exact cause is often 
unclear, although congenital anomalies may 
be the result of one or more genetic, infectious, 
nutritional or environmental factors. Prevention 
is possible in some cases, for example, through 
vaccination, fortification of foods with folic acid or 
iodine and adequate antenatal care. 
In 2015, the National Perinatal Epidemiology 
Centre (NPEC) reported a total of 488 perinatal 
deaths from 65,904 births of at least 500g 
birthweight or at least 24 weeks gestation across 
the 19 Irish maternity units. Stillbirths, early 
neonatal and late neonatal deaths accounted 
for 294 (60.2%), 166 (34.0%) and 28 (5.7%) 
respectively (O’FarrelI et al, 2017).The perinatal 
mortality rate (PMR) was 7.0 per 1,000 births 
and the corrected PMR (corrected for congenital 
anomaly) was 4.3 per 1,000 births  The corrected 
PMR across the 19 Irish maternity units ranged 
from 1.1 to 8.1 per 1,000 births in 2015.Major 
congenital anomaly was the primary cause of 
death in almost sixty percent (n=98, 59.0%) 
of the  166 early neonatal deaths that occurred 
in 2015. Chromosomal disorder accounted for 
seventeen percent of the 98 neonatal deaths 
due to congenital anomaly (n=17 of 98, 17.3% %). 
Recent regional Irish data showed that congenital 
abnormalities accounted for 47% of deaths in 
the neonatal period and prematurity for 41% of 
deaths (Finn et al., 2014). In another Irish study, 
the principal causes of death were congenital 
malformations 34% (n=43), prematurity 49% 
(n=63) and asphyxia 11% (n=14). This study 
also showed that the most common diagnoses 
of the 43 neonatal deaths due to congenital 
malformations, were Trisomy 18, Trisomy 13, 
Potters sequence, anencephaly and congenital 
cardiac malformations (McCoy B et al., 2010). 
In contrast, current findings from the UK showed 
that major congenital anomaly was the primary 
cause of death in just 27.4% and 27.5% of early 
neonatal deaths respectively. (Allanson ER et 
al., 2016, Manktelow et al 2016). The legislation 
prohibiting termination of pregnancy and the 
lack of universal pregnancy anomaly scans 
in Ireland may be the major factors involved in 
this disparity. Lack of universal early pregnancy 
scanning in Ireland may also be partially 
responsible for the postnatal diagnosis of 
major congenital anomalies, such as Congenital 
Diaphragmatic Hernia (Chukwu J et al., 2009). 
Furthermore, several papers have shown that 
patient and health care professionals support 
routine antenatal scans and testing but this has 
yet to be implemented across all Irish maternity 
units (Lynch CM et al., 2007). 
2. Invited commentary: Early Neonatal Death in
Ireland and Congenital Anomalies
Eleanor Molloy and Bob McDonnell
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In Europe, the pregnancy outcome for 50-90% 
of major congenital anomalies, including many 
that can be classified as rare diseases, is a 
Termination Of Pregnancy for Fetal Anomaly 
(TOPFA). The proportion of women in Ireland 
going abroad for a TOPFA is estimated at 25-
30% for lethal anomalies such as anencephaly, 
and up to 38% for chromosomal trisomies (Mc 
Donnell et al, 2016). Using Congenital Heart 
Defects (CHD) as an example there are an 
estimated 36,000 liveborn children with CHD per 
annum in Europe and 3000 die as a TOPFA, late 
fetal death or early neonatal death. There was 
a large variation in TOPFA due to CHD between 
European countries, ranging from 0% to 32%. The 
rate of children liveborn with a CHD associated 
with Down syndrome was 0.5 per 1,000 births, 
with more than a fourfold variation between 
countries (Dolk H et al., 2011).
Interventions to improve management and 
outcomes:
Antenatal diagnosis of congenital anomaly has 
many benefits including informed discussion 
with families about management and optimal 
site of delivery whether in a regional centre or 
locally. In addition, the need for urgent tertiary 
and quaternary input may dictate the location 
of birth and the advent of the New Children’s 
Hospital with a maternity hospital attached 
will allow families to stay close to their baby 
requiring intensive medical care. Furthermore, 
there is evidence of improved outcomes with 
early recognition and antenatal transport to 
specialist centres (Javid PJ et al., 2004; Phibbs 
CS et al., 2007; Watson SI et al, 2014). Increased 
staffing and education in perinatal and 
paediatric palliative care services are required 
to allow rapid transfer home if this is the family’s 
preference. 
Planning of services and resources are 
hampered by the lack of a detailed clinical and 
surveillance registry and in recent years the 
NPEC has provided invaluable information to 
rectify this issue. The European Surveillance of 
Congenital Anomalies and Research (EUROCAT 
(www.eurocat-network.eu) is a network of 
population-based registers of congenital 
anomaly in Europe, with a common protocol 
and data quality review for all its member 
registries, covering 1.5 million annual births 
in 22 countries. In Ireland, there are three HSE 
regional EUROCAT registries providing congenital 
anomaly surveillance for the East, Southeast 
and South, with annual births of 25,742 (38.3%), 
7,104 (10.6%) and 9,263 (13.8%) respectively, 
representing a total of 62.6% of all national births 
(n= 67,295) in 2014. There is no congenital 
anomaly surveillance for the remaining 25,186 
(37.4%) births occurring in the remaining HSE 
regions. Due to a tightening of the interpretation of 
data protection legislation in recent years, some 
of the registries are experiencing difficulties 
in ascertaining cases, which can affect the 
accuracy of data. With appropriate legislation, 
congenital anomaly surveillance can be readily 
extended nationally. The forthcoming Health 
Information & Patient Safety Bill publication and 
enactment in 2017/2018 is expected to provide 
for national surveillance.
EUROCAT data includes live births, stillbirths 
and TOPFA. However, the proportion of mothers 
in Ireland who choose to go abroad for a TOPFA 
is generally unknown, although there are 
estimates, as previously discussed, based on 
individual studies of specific anomalies. The 
high proportion of pregnancies affected by 
major congenital anomalies in Europe ending 
in a TOPFA impacts on the variation in rates 
between Ireland and the rest of Europe with 
Ireland having a higher incidence of major 
congenital anomalies and higher perinatal and 
neonatal unadjusted mortality rates.  
The EUROCAT-EUROPLAN recommendations for 
the primary prevention of congenital anomalies, 
endorsed in 2013 by the European Union 
Committee of Experts on Rare Diseases, includes 
feasible and evidence-based measures from 
which national plans can adopt and implement 
actions based on country priorities (Taruscio D 
et al.,2015). 
National clinical pathways from the Royal College 
of Physicians of Ireland are integrating antenatal 
and postnatal early management of complex 
congenital anomalies such as congenital 
diaphragmatic hernia across multiple disciplines 
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and sites to ensure co-ordinated urgent and 
long-term care. Partnership with European and 
international collaborators is ongoing and there 
is an increased focus on parent and family 
support group involvement in research planning 
and implementation. 
Many congenital anomalies are rare diseases. 
The EU Commission (EU Commission, 2017) 
has mandated more effective co-ordinated 
management and care of rare diseases in 
member states through National Rare Disease 
Plans (Department of Health, 2014), and 
European Reference Networks (Health Service 
Executive, 2014). The vital diagnostics and 
clinical genetics services have enhanced 
diagnosis of patients with rare disorders to 
optimize care. Rapid developments in genomics 
also offer diagnosis and classification of 
diseases to allow targeted therapeutic options 
for children with rare disorders, which is 
promoted by the EU with the European Medicines 
Agency (EMA). This information is especially 
valuable for parents and families in planning 
their child’s management with the clinical 
team and future pregnancy outcomes. New 
treatments for conditions currently considered 
life-limiting can be developed in partnership 
with families and health care providers. A good 
example is Spinraza (nusinersen), the first 
drug approved to treat children and adults 
with spinal muscular atrophy (SMA). The U.S. 
Food and Drug Administration (FDA) recently 
approved Spinraza to treat SMA, a rare and often 
fatal genetic disease affecting muscle strength 
and movement (Finkel RS et al., 2017). The 
recognition of the association between Zika virus 
outbreaks and an increase in microcephaly and 
other congenital malformations, has resulted 
in enhanced public health surveillance and 
vaccination research. 
Paediatric pathology services are crucial to 
diagnose rare conditions including postmortem 
diagnosis of rare diseases. A study by Brodlie et 
al found that over a quarter of neonatal autopsies 
yielded new information, which in 3% of cases 
was crucial (Brodlie M et al., 2002). However, 
in 2015 the NPEC reported that an autopsy 
was undertaken in only 53.3% of all stillbirths 
and 14.5% of early neonatal deaths in Ireland, 
resulting in an autopsy uptake rate of 50.4% of 
all perinatal deaths (O’Farrell I et al, 2017).  
The evolution and collaboration of International 
congenital anomaly and rare disease registers 
and networks on projects regarding children with 
rare diseases will be especially valuable to Irish 
researchers. The International Clearinghouse for 
Birth Defects Surveillance and Research (www.
icbdsr.org) already collaborates in projects with 
the EUROCAT network. In 2010, the 63rd World 
Health Assembly passed a resolution calling 
for Member States to agree to promote primary 
prevention and improve the health of children 
with congenital anomalies by: developing and 
strengthening registration and surveillance 
systems; developing expertise and building 
capacity; strengthening research and studies 
on etiology, diagnosis and prevention and 
promoting international cooperation.
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3. Stillbirths: Specific findings
Figure 3.1: Primary cause of death in stillbirths (right) and detailed cause in cases of major 
congenital anomaly (left) in 2015
Cause of death in stillbirths
Major congenital anomaly was the primary 
cause of death in over one in four (n=79, 26.9%) 
of the 294 stillbirths that occurred in 2015 
(Figure 3.1). There was a chromosomal disorder 
in over sixty percent of the 79 stillbirths due to 
congenital anomaly (n=52, 65.8%). In these 
cases, over half were diagnosed by cytogenetic 
analysis (n=30, 57.7%). Anomalies of the central 
nervous system (n=3), the cardiovascular 
system (n=3), the musculo-skeletal system 
(n=3) and urinary tract (n=2) collectively 
caused a further 11 (13.9%) stillbirths.
Specific placental conditions were diagnosed 
in one quarter (n=71, 24.1%) of stillbirth cases. 
The most commonly occurring placental 
condition was maternal vascular malperfusion 
(n=26 of 71, 36.6%). In under ten percent 
of stillbirths (n=24, 8.2%) infection was the 
main cause of death, all but one case involved 
chorioamnionitis (n=23, 95.8%). Likewise, 
in less than ten percent of stillbirths, specific 
fetal conditions was the main cause of death. 
Antepartum or intrapartum haemorrhage 
(n=21, 7.1%) and mechanical factors (n=19, 
6.5%) were the next most common cause of 
death. The majority of mechanical factors were 
due to the umbilical cord around the baby’s 
neck or another entanglement or knot in the 
umbilical cord.
For sixteen percent of stillbirths (n=46, 15.6%), 
the cause of death was unexplained. This 
is similar to the proportion in 2014 (n = 49, 
14.8%) but lower than the proportion in 2013 
(26.3%) and in 2012 (22.7%). For over forty 
percent of the stillbirths of unexplained cause 
(n=19, 41.3%), it was reported that there were 
no antecedents or associated obstetric factors. 
For all of these cases, an autopsy was either 
performed (n=11, 57.9%) or was offered (n=8, 
42.1%). A detailed listing of the main cause of 
death for the 294 stillbirths is given at the end 
of this section.
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Factors influencing the delivery management 
of women experiencing antepartum stillbirths 
include maternal choice, maternal wellbeing, 
risk of developing severe medical complications 
and previous obstetric history. Management of 
clinical care may involve planned induction of 
labour, awaiting spontaneous labour or in some 
cases elective delivery by caesarean section.40
In 2015, 270 women experienced antepartum 
stillbirth (Table 3.2). The management of clinical 
care (i.e. whether the care involved: planned 
induction of labour or awaiting spontaneous 
labour or elective delivery by caesarean 
section) was recorded for 264 of the 270 
women who experienced antepartum stillbirth. 
Labour was induced for over two-thirds of the 
264 women who experienced antepartum 
stillbirth (n=178, 67.4%) whereas labour was 
spontaneous for 17.0% (n=45). It can be seen 
from Figure 3.2 that the time from diagnosis 
of fetal demise to delivery was different for 
women whose labour was induced than it was 
for women whose labour was spontaneous. The 
confirmation of death and delivery took place 
on the same day for 49% (n=22 of 45, 48.6%) 
of the women whose labour was spontaneous. 
For women whose labour was induced, it was 
common for up to three days to pass between 
diagnosis and delivery. As can be observed 
from Figure 3.2, a small number of antepartum 
stillbirths (n=8), were delivered more than 
two weeks after confirmation of fetal demise. 
Of these eight cases, all but one case were 
associated with a multiple births.
Figure 3.2: Time from confirmation of fetal demise to delivery for women who experienced antepartum stillbirth in 2015
40 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: 
Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical 
Programmes, Health Service Executive.
Management of women experiencing antepartum stillbirths
Note: Data on the management of clinical care was missing for six cases.
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Indication for caesarean section n(%)
Elective: At a time to suit the woman or the maternity team 20(46.5)
Urgent: Maternal or fetal compromise which is not immediately life threatening 11(25.6)
Emergency: Immediate threat to life of woman or baby 12(27.9)
Table 3.1: Indication for caesarean section in women experiencing antenatal stillbirth in 2015
41 Clinical Practice Guideline No 4 (2011). Investigation and management of late fetal intrauterine death and stillbirth: 
Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical 
Programmes, Health Service Executive.
42 Darmstadt G, Yakoob M, Haws R, Menezes E, Soomro T and Bhutta Z. Reducing stillbirths: interventions during labour. BMC 
Pregnancy and Childbirth 2009;9 (Suppl 1):s6
43 Manktelow BM, Smith LK, Evans TA, Hyman-Taylor P, Kurinczuk JJ, Field DJ, Smith PW, Draper ES, on behalf of the MBRRACE-
UK collaboration. Perinatal Mortality Surveillance Report UK Perinatal Deaths for births from January to December 2013. 
Leicester: The Infant Mortality and Morbidity Group, Department of Health Sciences, University of Leicester. 2015.
Intrapartum stillbirths
It has been suggested that the comparatively 
low proportion of intrapartum stillbirths in 
high-income countries indicates that fetal 
deaths occurring in labour, in non-anomalous 
babies, are most likely preventable with quality 
intrapartum care.42 Intrapartum deaths in this 
audit were identified by a specific question on 
the NPEC Perinatal Death Notification Form as 
to whether the baby was alive at the onset of 
care in labour. This was not known in six cases 
(Table 3.2), four of which involved the baby 
being born before arrival to hospital. There 
were 18 cases of stillbirth where the baby was 
known to be alive at the onset of care in labour. 
Thus, intrapartum deaths accounted for 6.1% 
of stillbirths in Ireland in 2015. This was lower 
than the proportion of intrapartum deaths 
reported in the UK countries in 2013 (the most 
up to date published figures), ranging from 
8.4% in England to 8.6% in Northern Ireland, 
10.9% in Wales and 13.2% in Scotland.43
Vaginal birth is the recommended mode 
of delivery for most women experiencing 
antepartum stillbirth, but caesarean section 
may be clinically indicated in some cases.41 
Vaginal cephalic delivery was the most common 
mode of delivery in cases of antepartum stillbirth 
(n=160, 59.3%) and cases of intrapartum 
stillbirth (n=11, 61.2%).
In 33 cases of antepartum stillbirth (12.5%), 
the intended mode of delivery was a planned 
caesarean section and ultimately, caesarean 
section was the mode of delivery for 49 women 
(18.1%; 42 pre-labour caesarean sections and 
seven caesarean sections performed after 
onset of labour).
The indication for caesarean section was 
recorded for 43 of the 49 women who were 
delivered by caesarean section. Of the 43 women 
who were delivered by caesarean section, the 
indication for caesarean section was classified 
as ‘elective’ in 46.5% of the cases, 25.6% were 
‘urgent’ and 27.9% were ‘emergency’ (Table 3.1). 
Over forty percent (n=22, 44.9%) of the 49 
women had a caesarean section previously and 
45% (n=22, 44.9%) had a multiple delivery, each 
of which were factors that may have influenced 
the mode of delivery.
The location of delivery for all antepartum 
stillbirths was in obstetric-led maternity units.
Note: Indication unknown in six cases
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Major congenital anomaly was the primary 
cause of death for 44% of the 18 intrapartum 
deaths (n= 8, 44.4%). Infection was the second 
most common cause of death, accounting for 
five (27.8%) of the 18 intrapartum deaths. All 
infection cases involved chorioamnionitis. 
There was no clustering by hospital in the 
intrapartum deaths due to causes other than 
congenital anomaly. 
 n(%)
Baby alive at onset of care in labour 18(6.1)
Baby not alive at onset of care in labour 238(81)
Never in labour 32(10.9)
Not known 6(2)
Table 3.2: Life status of baby at the onset of care in labour for stillbirths in 2015
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Table 3.3: Stillbirth main cause of death in 2011-2015, NPEC Classification System
2011 2012 2013 2014 2015
N=318 N=304 N=301 N=330 N=294
Major congenital anomaly 81(25.5%) 80(26.3%) 69(22.9%) 83(25.2%) 79(26.9%)
Central nervous system 10 11 10 9 3
Cardiovascular system 10 5 9 5 3
Respiratory system - 1 1 - -
Gastro-intestinal system 3 2 2 2 -
Musculo-skeletal system 3 1 1 1 3
Multiple anomalies 10 10 5 3 3
Chromosomal disorders 39 38 33 57 52
Metabolic disorders - - - - -
Urinary tract 2 2 6 4 2
Other major congenital anomaly 4 10 2 2 13
Specific placental conditions* 52(16.4%) 73(24.0%) 66(21.9%) 82(24.8%) 71(24.1%)
Maternal vascular malperfusion** 22 32 26
Fetal vascular malperfusion** 16 16 18
Cord pathology** 9 17 15
Delayed villous maturation*** 8 7 8
Chorioamnionitis - - 1 1 -
Villitis - 4 2 5 3
Other placental condition 19 20 8 4 1
Mechanical 20(6.3%) 25(8.2%) 30(10.0%) 28(8.5%) 19(6.5%)
Prolapse cord 1 1 2 3 3
Cord around neck 8 14 18 17 11
Other cord entanglement or knot 11 10 9 7 5
Uterine rupture before labour - - 1 1 -
Uterine rupture during labour - - - - -
Mal-presentation - - - - -
Shoulder dystocia - - - - -
Antepartum or intrapartum haemorrhage 35(11.0%) 21(6.9%) 26(8.6%) 32(9.7%) 21(7.1%)
Praevia 2 - - - 1
Abruption 33 21 26 31 20
Uncertain haemorrhage - - - 1 -
*The main placental pathology associated with perinatal death is reported.
**Reported abnormal placental histology was not classified under these categories for the years 2011 and 2012
*** The term ‘Delayed villous maturation’ (DVM) has replaced conditions previously reported as ‘Placental maturation defect’. DVM includes distal villous 
immaturity and delayed villous maturation.
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Infection 17(5.3%) 16(5.3%) 17(5.6%) 22(6.7%) 24(8.2%)
Maternal --
    Bacterial 1 - - 2 
    Syphilis 1 - - - -
    Viral diseases - 2 1 - -
    Protozoal - - - - -
    Group B Streptococcus 2 1 3 2 -
    Other maternal infection - - 1 - 1
Ascending infection -
    Chorioamnionitis 13 11 9 14 23
    Other ascending infection - 2 3 2 -
Specific fetal conditions 15(4.7%) 9(3.0%) 14(4.7%) 21(6.4%) 24(8.2%)
Twin-twin transfusion 5 4 6 9 11
Feto-maternal haemorrhage 5 2 4 6 7
Non immune hydrops 3 - 1 2 4
Iso-immunisation - - - 1 -
Other fetal condition 2 3 3 3 2
Intra-uterine growth restriction 17(5.3%) 6(2.0%) 5(1.7%) 7(2.1%) 8(2.7%)
IUGR - Suspected antenatally 4 4 2 5 7
IUGR - Observed at delivery 7 1 1 2 -
IUGR - Observed at post mortem 6 1 2 1
Associated obstetric factors 7(2.2%) 3(1.0%) 2(0.7%) 1(0.3%) -
Intracranial haemorrhage - - - - -
Birth injury to scalp - - - - -
Fracture - - - - -
Other birth trauma - - - - -
Intrapartum asphyxia 5 - - - -
Polyhydramnios - - - - -
Oligohydramnios - - - - -
Premature rupture of membranes - - - - -
Prolonged rupture of membranes  - - - 1 -
Spontaneous premature labour - 2 2 - -
Other obstetric factors 2 1 - - -
Maternal disorder 6(1.9%) 0(0.0%) 1(0.3%) 3(0.9%) 2(0.7%)
Pre-existing hypertensive disease 1 - - - -
Diabetes 2 - - - 1
Other endocrine conditions - - - - -
Thrombophilias - - - 1 -
Obstetric cholestasis - - - - -
Drug misuse - - - - -
Uterine anomalies 1 - - 1 -
Other maternal disorder 2 - 1 1 1
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Hypertensive disorders of pregnancy 4(1.3%) 2(0.7%) 0(0.0%) 2(0.6%) -
Pregnancy induced hypertension 1 - - 2 -
Pre-eclampsia toxaemia 3 2 - - -
HELLP syndrome - - - - -
Eclampsia - - - - -
Unexplained 64(20.1%) 69(22.7%) 71(23.6%) 49(14.8%) 46(15.6%)
No antecedents or associated obstetric factors 41 30 26 28 19
Antecedents or associated obstetric factors present 20 38 36 18 25
Very limited information available - - 4 -
Pending post mortem or other investigation 3 1 5 3 2
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Cause of early neonatal death
The cause of early neonatal deaths was classifi ed 
using both the NPEC Neonatal Classifi cation 
System and the NPEC Maternal and Fetal 
Classifi cation System in order to identify both 
the primary neonatal condition causing the 
death and the underlying main antecedent or 
obstetric factor associated with the death.
Major congenital anomaly was the primary 
cause of death for almost sixty percent (n=98, 
59.0%) of the 166 early neonatal deaths (Figure 
4.1). Respiratory disorder was the second most 
common cause of death, accounting for almost 
one in four (n=41, 24.7%) of early neonatal 
deaths. Neurological disorders was the next 
most common cause of death, causing ten 
percent of early neonatal deaths (n=17, 10.2%). 
Three deaths (1.8%) were unexplained pending 
post mortem or other investigation. A detailed 
listing of the main cause of death for the 166 
early neonatal deaths is given at the end of this 
section of the report.
4. Early neonatal deaths: Specifi c fi ndings
Figure 4.1: Primary cause of early neonatal death (upper chart) and cases of major congenital anomaly (bottom right) 
and detailed cause in cases of respiratory disorder (bottom left) in 2015 
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Major congenital anomalies
The type of major congenital anomaly that 
caused 98 of the 166 neonatal deaths 
is illustrated in Figure 4.1 (right chart). 
Anomalies of the urinary tract were the most 
common type of major congenital anomaly, 
occurring in almost one in five cases 
(n=19, 19.4%). The other most frequently 
occurring anomalies included, chromosomal 
disorders (n=17, 17.3%), and disorders of the 
cardiovascular system (n=16, 16.3%). For 
over half of the 17 neonatal deaths attributed 
to a chromosomal disorder, the diagnosis was 
made by cytogenetic analysis (n=10, 58.8%).
Respiratory disorders
Of the 41 early neonatal deaths caused by 
respiratory disorder, over three quarters 
(n=31, 75.6%) were due to severe pulmonary 
immaturity (Figure 4.1, left chart). Pulmonary 
hypoplasia occurred in one in ten cases (n=4, 
9.8%). All but five of the 41 early neonatal 
deaths attributed to respiratory disorder 
occurred in babies delivered before 28 
weeks gestation (Table 4.1). This pattern of 
gestational age was in marked contrast to the 
early neonatal deaths due to major congenital 
anomaly and to those due to all other causes 
(Table 4.1).
Neurological disorders
A neurological disorder was attributed as the 
main cause of 17 early neonatal deaths. For 
13 of these cases, the condition involved was 
hypoxic ischaemic encephalopathy (HIE) and 
for four cases, the condition involved was 
intraventricular/periventricular haemorrhage. 
Ten of these 13 HIE cases occurred in babies 
with a gestational age of 37-41 weeks. All 
of these ten early neonatal deaths had an 
autopsy performed and became coroner 
cases. Table 4.2 details the gestational age, 
customised birthweight centile and main 
antecedent or obstetric factor associated with 
the 17 early neonatal deaths attributed to 
neurological disorders.
Broad main cause of death <22 22-27 28-31 32-36 37-41 ≥42
weeks weeks weeks weeks weeks weeks
Respiratory disorder 0 36 3 2 0 0
0% 87.8% 7.3% 4.9% 0% 0%
Major congenital anomaly 0 6 11 36 44 1
0% 6.1% 11.2% 36.7% 44.9% 1%
All Other 1 3 5 6 12 0
3.7% 11.1% 18.5% 22.2% 44.4% 0%
Table 4.1: Gestational age distribution in neonatal deaths by broad main cause of death in 2015
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Neurological Gestational Birthweight Main antecedent or obstetric factor Autopsy Performed
Disorder age centile associated with the death (Yes/No)
IVH/PVH 25th 26th Spontaneous premature labour  Unknown
IVH/PVH 26th 2nd Abruption No
IVH/PVH 27th 4th Unexplained but with some reported No
antecedent or associated obstetric factors 
IVH/PVH 29th 0 Uterine rupture before labour No
HIE 28th 86th Maternal vascular malperfusion* Yes (coroner case)
HIE 32nd 63rd Abruption No
HIE 35th 69th Abruption No
HIE 38th 88th Delayed villous maturation* Yes (coroner case)
HIE 38th 48th No Antecedent or Yes (coroner case)
Associated Obstetric Factors
HIE 39th 34th Hypocoiled cord* Yes (coroner case)
HIE 39th 99th Uterine rupture during labour Yes (coroner case)
HIE 39th 92nd No antecedent or Yes (coroner case)
associated obstetric factors
HIE 40th 9th Hypercoiled cord* Yes (coroner case)
HIE 40th 7th No antecedent or Yes (coroner case)
associated obstetric factors 
HIE 41st 99th Fetal vascular malperfusion* Yes (coroner case)
HIE 41st 24th Fetal vascular malperfusion* Yes (coroner case)
HIE 41st 31st Abruption Yes (coroner case)
Note: *Placental disease. IVH/PVH = Intraventricular/periventricular haemorrhage; HIE = hypoxic ischaemic encephalopathy. 
Table 4.2: Details of early neonatal deaths due to neurological disorders in 2015
 57
Condition and management at birth
The NPEC Perinatal Death Notification Form 
(Appendix E) records the condition, in terms of 
respiratory activity and heart rate shortly after 
delivery, of babies who die in the early neonatal 
period. For most of these babies (n=98, 
59.4%; unknown for one case), spontaneous 
respiratory activity was absent or ineffective 
at five minutes following delivery and for 42% 
(n=67, 41.9%, unknown for six cases) the heart 
rate was persistently less than 100 beats per 
minute.
In most cases of early neonatal death, active 
resuscitation was offered in the delivery 
room (Table 4.3). In cases where active 
resuscitation was not offered, major congenital 
anomaly was involved in three quarters of 
cases (n=51, 75.0%), followed by respiratory 
disorders (n=14, 20.6%).  The cause of death 
for the remainder was as follows: neurological 
disorders (n=1, 1.5%), pre-viable (n=1, 1.5%), 
and sudden unexpected death (n=1, 1.5%).
Half of the babies were admitted to a neonatal 
unit in the hospital of delivery (n=86, 51.8%) 
and almost one in five babies (n=32, 19.3%) 
were transferred to another unit (Table 4.3). 
Such admission and transfer depended on 
whether active resuscitation had been offered 
in the delivery room. Admission to a neonatal 
unit followed over eighty percent of the cases 
offered active resuscitation (n=79, 83.2%) 
compared to one in ten not offered active 
resuscitation (n=7, 10.3%). Thirty percent 
of cases offered active resuscitation were 
transferred to another unit (n=28, 29.5%) 
compared to just four percent of babies not 
offered active resuscitation (n=3, 4.4%).
Management Active resuscitation offered * All
Yes (95, 41.7%)  No (68, 58.3%) 166
Baby admitted to neonatal unit 79(83.2%) 7(10.3%) 86(51.8%)
Baby transferred to another unit 28(29.5%) 3(4.4%) 32(19.3%)
Active resuscitation in the delivery room includes BMV, PPV, intubation, cardiac massage. 
Note: Data on active resuscitation was unknown for three cases.
Table 4.3: Management at birth of babies who died within the first week of birth, 2015
Age of neonate at death
Over two thirds of the early neonatal deaths 
occurred within 24 hours of delivery (Table 
4.4). Major congenital anomaly and severe 
pulmonary immaturity were the main cause 
of death in 63.9% (n=69) and 25.9% (n=28) of 
these cases, respectively.
Completed days 0 1 2 3 4 5 6
Number 108 18 12 12 11 - 5
% 65.1 10.8 7.2 7.2 6.6 - 3
Cumulative % 65.1 75.9 83.1 90.4 97 - 100
Table 4.4: Age of neonate at death, 2015
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Location of neonatal death
The vast majority of early neonatal deaths 
occurred either in the neonatal unit, the labour 
ward, or in another maternity unit ward (Table 
4.5). Less than one in ten deaths occurred in 
a paediatric centre.
Place of death n(%)
At home 2(1.3)
Labour ward 55(34.4)
Neonatal unit 73(45.6)
Ward of the maternity unit 16(10.0)
Paediatric centre 14(8.8)
Table 4.5: Location of neonatal death, 2015
All 55 neonatal deaths that occurred in the 
labour ward occurred within 24 hours of 
delivery. These 55 deaths in the labour ward 
accounted for over half (53.9%) of the neonatal 
deaths that occurred in the first day. A further 
29.4% (n=30) of first day neonatal deaths 
occurred in a neonatal unit. As detailed in Table 
4.4, the daily number of neonatal deaths was 
significantly lower once 24 hours had elapsed 
after delivery. Almost three quarters of the 
neonatal deaths after 1-6 completed days 
happened in a neonatal unit (n=43, 74.1%) and 
a further 15.5% of these deaths (n=9) occurred 
in a paediatric centre (Figure 4.2).
Figure 4.2: Place of neonatal death 0-6 complete days after birth, 2015
Note: Data on location of death missing for six cases.
Note: Data on location of death missing for six cases.
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Table 4.6: Early neonatal main cause of death in 2011-2015, NPEC Classification System
2011 2012 2013 2014 2015
N=138 N=141 N=162 N=141 N=166
Major congenital anomaly 71(51.4%) 68(48.2%) 92(56.8%) 68(48.2%) 98(59%)
Central nervous system 15 7 19 7 11
Cardiovascular system 8 7 9 7 16
Respiratory system 2 2 1 2 1
Gastro-intestinal system 2 2 2 1 4
Musculo-skeletal system 2 2 1 3 5
Multiple anomalies 8 12 17 8 11
Chromosomal disorders 20 17 25 26 17
Metabolic disorders (in-born errors of metabolism) 1 2 - - 1
Urinary tract 6 13 9 10 19
Other major congenital anomaly 7 4 9 4 13
Pre-viable (<22 weeks) - 1(0.7%) 1(0.6%) 1(0.7%) 1(0.6%)
Respiratory disorders 45(32.6%) 44(31.2%) 53(32.7%) 46(32.6%) 41(24.7%)
Severe pulmonary immaturity 39 29 32 35 31
Surfactant deficiency lung disease - 9 14 5 1
Pulmonary hypoplasia 3 1 2 4 4
Meconium aspiration syndrome - - - - 
Primary persistent pulmonary hypertension - 1 - - 1
Chronic lung disease/bronchopulmonary dysplasia - - - - 
Other respiratory disorder 3 4 5 2 4
Gastro-intestinal disease 1(0.7%) 3(2.1%) 1(0.6%) 2(1.4%) -
Necrotising enterocolitis 1 2 1 2 -
 Other gastro-intestinal disease - 1 - -
Neurological disorder 7(5.1%) 14(9.9%) 10(6.2%) 9(6.4%) 17(10.2%)
Hypoxic-ischaemic encephalopathy 6 10 9 7 13
Intraventricular/periventricular haemorrhage - 2 1 2 4
Other neurological disorder 1 2 - - -
Infection 6(4.3%) 4(2.8%) 3(1.9%) 12(8.5%) 3(1.8%)
Sepsis 4 2 1 7 -
Pneumonia - 1 1 2 1
Meningitis - - - 1 -
Other infection 2 1 1 2 2
Injury/Trauma - - - - -
Other specific causes 2(1.4%) 3(2.1%) 1(0.6%) - 2(1.2%)
Malignancies/tumours - - - - -
 Other specific cause 2 3 1 - 2
Sudden unexpected deaths 1(0.7%) 2(1.4%) - 1(0.7%) 1(0.6%)
Sudden infant death syndrome (SIDS) 1 2 - 1 1
Infant Deaths - Cause Unascertained - - - - -
Unexplained 5(3.6%) 2(1.4%) 1(0.6%) 2(1.4%) 3(1.8%)
No antecedents or associated obstetric factors - 1 - - -
Antecedents or associated obstetric factors present - - - - -
Very limited information available 5 - - - -
Pending post mortem or other investigation - 1 1 2 3
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The investigation of perinatal deaths due to 
intrapartum events is valuable in assessing 
quality of care. These deaths are unexpected 
and include stillbirths alive at the onset of 
professional care in labour and neonatal 
deaths. Traditionally intrapartum deaths 
referred to babies who were alive at onset 
of labour but stillborn. The inclusion of 
neonatal deaths facilitates the assessment 
of all perinatal deaths that may have an 
intrapartum origin.
We reviewed perinatal deaths reported in 
2015, focusing on cases with a gestational 
age of at least 34 weeks and a birthweight of 
at least 2,500g who were alive at the onset of 
labour and whose death was not due to major 
congenital anomaly, infection or placental 
abruption. In addition, babies who were 
delivered by pre-labour caesarean section 
were not included. 
In 2015, there were 37 cases of perinatal death 
with a gestational age of at least 34 weeks 
and a birthweight of at least 2,500g who 
were alive at the onset of labour. Of these 37 
perinatal deaths, 26 were either due to major 
congenital anomaly, infection or abruption 
(major congenital anomaly, n=24; infection, 
n=1; or abruption, n=1). Therefore, in total 
in 2015, there were 11 perinatal deaths (two 
stillbirths and nine early neonatal deaths) 
associated with intrapartum events with a 
gestational age of at least 34 weeks and a 
birthweight of at least 2,500g who were alive 
at the onset of labour and whose death was 
not due to major congenital anomaly, infection 
or placental abruption. Nine of the 11 deaths 
were coroner cases. Details of the cases are 
provided in Table 5.1.
5. Perinatal deaths associated with intrapartum events
Type of Gestational Birthweight Main antecedent or Neonatal cause  Autopsy
perinatal age (weeks) centile obstetric factor of death Performed
death associated with the death Yes/No
SB 41 83 Cord compression Not applicable Yes
SB 40 8 Hypercoiled cord* Not applicable Yes
ENND 39 34 Hypocoiled cord* HIE Yes (coroner case)
ENND 41 24 Fetal vascular malperfusion* HIE Yes (coroner case)
ENND 41 99 Fetal vascular malperfusion* HIE Yes (coroner case)
ENND 38 88 Delayed villous maturation* HIE Yes (coroner case)
ENND 39 99 Intrapartum uterine rupture HIE Yes (coroner case)
ENND 38 4 No antecedents or associated obstetric factors SIDS Yes (coroner case)
ENND 40 7 No antecedents or associated obstetric factors HIE Yes (coroner case)
ENND 39 92 No antecedents or associated obstetric factors HIE Yes (coroner case)
ENND 38 48 No antecedents or associated obstetric factors HIE Yes (coroner case)
Note: *Placental diseases. SB=Stillbirth; ENND=Early neonatal death; HIE=hypoxic ischaemic encephalopathy; SIDS=sudden infant death syndrome. All but 
two of the 11 intrapartum deaths were coroner cases.
Table 5.1: Details of perinatal deaths in 2015 associated with intrapartum events
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Data relating to 28 late neonatal deaths 
occurring in 2015 were reported to the NPEC for 
the purposes of this clinical audit. At the time 
of writing, finalised figures for late neonatal 
deaths in 2015 were not yet published by 
the Central Statistics Office (CSO). In the 
five most recent years for which data are 
available, 2010-2014, the annual number of 
late neonatal deaths fluctuated between 27 
and 41 with no discernible trend. For the year 
2014, there were 38 late neonatal deaths 
according to the published CSO figures and 
33 late neonatal deaths were reported to the 
NPEC. Thus for 2014, the numbers reported to 
the NPEC were slightly lower than the figures 
reported by the CSO. Maternity hospitals may 
not be notified of the late neonatal death of 
a baby delivered in their unit if the baby was 
transferred to a paediatric unit or discharged 
home. The NPEC is working with colleagues 
in the relevant hospitals (maternity and 
paediatric) and with the National Office of 
Clinical Audit to address this issue.
Given the notification issue and the limited 
number of late neonatal deaths reported, this 
section of the report provides a brief summary 
of the submitted data as well as the detailed 
listing of the main cause of the 28 deaths 
according to the NPEC Classification System.
Similar to early neonatal deaths, over half 
of late neonatal deaths were due to major 
congenital anomaly (n=15, 53.6%). The next 
most common causes were infection (n=4, 
14.3%), respiratory disorders (n=3, 10.7%), 
gastrointestinal disorders (n=3, 10.7%), 
neurological disorders (n=2, 7.1%) and sudden 
infant death syndrome (n=1, 3.6%).
Table 6.1 describes a range of characteristics 
of the babies who died in the late neonatal 
period. Most of the babies who died in the late 
neonatal period were male: this fluctuates 
from year to year. 
Forty two percent of babies who died in the late 
neonatal period in 2015 were born by vaginal 
cephalic delivery and under half (46.1%) 
were delivered by caesarean section. Most 
had a gestational age of at least 37 weeks at 
birth but sixty percent (n=17, 60.7%) had a 
birthweight less than 2,500 grams. Over forty 
percent of babies were small for gestational 
age (SGA; <10th centile).
In 2015, the proportion of late neonatal deaths 
was found to decrease across the second, 
third and fourth weeks of life. For example, the 
proportion of late neonatal deaths decreased 
from 60.7% in week two to 25.0% in week three 
to 14.3% in week four (Table 6.1).
Half of late neonatal deaths in 2015 occurred 
in the neonatal unit and almost one third died 
in a paediatric centre.
6. Late neonatal deaths: Specific findings
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Table 6.1: Characteristics of late neonatal deaths, 2012 - 2015
2012, N=40 2013, N=37 2014, N=33 2015, N=28
Infant sex 
Male 18 (45.0) 22 (59.5) 22 (66.7) 19 (73.1)
 Female 22 (55.0) 15 (40.5) 11 (33.3) 7 (26.9)
Mode of delivery 
Spontaneous vertex delivery 22 (5.0) 18 (48.6) 13 (39.4) -
           Vaginal cephalic delivery - - - 11 (42.3)
           Vaginal breech delivery - - - 1 (3.8)
Pre-labour caesarean section 10 (25.0) 9 (24.3) 10 (30.3) 9 (34.6)
Caesarean section after onset of labour 4 (10.0) 7 (18.9) 9 (27.3) 3 (11.5)
Forceps 1 (2.5) - - -
Assisted breech 2 (5.0) 2 (5.4) 1 (3) 1 (3.8)
Ventouse 1 (2.5) 1 (2.7) 1 (3.8)
Gestational age at delivery
22-27 weeks 15 (37.5) 11 (29.7) 11 (33.3) 8 (28.6)
28-31 weeks 1 (2.5) 3 (8.1) 9 (27.3) 2 (7.1)
32-36 weeks 6 (15.0) 2 (5.4) 4 (12.1) 7 (25)
37-41 weeks 18 (45.0) 21 (56.8) 9 (27.3) 10 (35.7)
42+ weeks - - - 1 (3.6)
Birthweight - - - -
           <500g - - 2 (6.1) 1 (3.6)
500<1000g 16 (40.0) 11 (29.7) 9 (27.3) 8 (28.6)
1000<1500g - 1 (2.7) 6 (18.2) 2 (7.1)
1500<2000g 5 (12.5) 3 (8.1) 2 (6.1) 2 (7.1)
2000<2500g 6 (15.0) 2 (5.4) 2 (6.1) 4 (14.3)
2500<3000g 5 (12.5) 7 (18.9) 3 (9.1) 3 (10.7)
3000<3500g 4 (10.0) 7 (18.9) 4 (12.1) 5 (17.9)
3500<4000g 1 (2.5) 5 (13.5) 4 (12.1) 3 (10.7)
4000g+ 3 (7.5) 1 (2.7) 1 (3) -
Customised birthweight centile category
<3rd 13 (32.5) 3 (8.1) 6 (18.2) 8(34.8)
<10th 17 (42.5) 8 (21.6) 9 (27.3) 10(43.5)
10-49th 13 (32.5) 16 (43.2) 10 (30.3) 6(26.1)
50-89th 6 (15.0) 11 (29.7) 9 (27.3) 7(25.0)
90th+ 4 (10.0) 2 (5.4) 5 (15.2) -
Timing of death 
2nd week of life 23 (57.5) 15 (40.5) 20 (60.6%) 17 (60.7)
3rd week of life 10 (25.0) 9 (24.3) 6 (18.2%) 7 (25)
4th week of life 7 (17.5) 13 (35.1) 7 (21.2%) 4 (14.3)
Location of death 
Home 6 (15.0) 5 (13.5) - 4 (14.3)
Ward of the maternity unit 1 (2.5) 1 (2.7) - -
Neonatal unit 18 (45.0) 21 (56.8) 24 (72.7) 14 (50.0)
In transit home 1 (2.5) - 1 (3.6)
Paediatric centre 14 (35.0) 10 (27.0) 9 (27.3) 9 (32.1)
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Table 6.2: Late neonatal main cause of death in 2011-2015, NPEC Classification System
2011 2012 2013 2014 2015
N=35 N=40 N=37 N=33 N=28
Major congenital anomaly 20(57.1%) 15(37.5%) 18(48.6%) 19 (57.6%) 15 (53.6%)
Central nervous system 2 2 2 3 1
Cardiovascular system 5 5 4 5 5
Respiratory system 1 1 - - 1
Gastro-intestinal system 1 - 1 - 1
Musculo-skeletal system 1 - 1 - -
Multiple anomalies 1 2 3 1 -
Chromosomal disorders 6 4 4 7 7
Metabolic disorders - - 1 2 -
Urinary tract - - 1 1 -
Other major congenital anomaly 3 1 1 - -
Pre-viable (<22 weeks) - - - - 
Respiratory disorders 5(14.3%) 9(22.5%) 5(13.5%) 6 (18.2%) 3 (10.7%)
Severe pulmonary immaturity 5 5 4 2 3
Surfactant deficiency lung disease - 1 - 4 -
Pulmonary hypoplasia - - - - -
Meconium aspiration syndrome - - - - -
Primary persistent pulmonary hypertension - - - - -
Chronic lung disease/bronchopulmonary dysplasia - - 1 - -
Other respiratory disorder - 3 -
Gastro-intestinal disease 2(5.7%) 6(15.0%) 1(2.7%) 4 (12.1%) 3 (10.7%)
Necrotising enterocolitis 2 5 1 4 3
Other gastro-intestinal disease - 1 - - -
Neurological disorder 2(5.7%) 1(2.5%) 7(18.9%) 1 (3.0%) 2 (7.1%)
Hypoxic-ischaemic encephalopathy 1 - 3 - 1
Intraventricular/periventricular haemorrhage - - 4 1 1
Other neurological disorder 1 1 - - -
Infection 4(11.4%) 4(10.0%) 1(2.7%) 2 (6.1%) 4 (14.3%)
Sepsis 4 3 1 2 1
Pneumonia - - - - -
Meningitis - - - - 2
Other infection - 1 - - 1
Injury/Trauma - - - 1 (3.0%) -
Other specific causes - - - - -
Malignancies/tumours - - - - -
Other specific cause - - - - -
Sudden unexpected deaths - 3(7.5%) 4(10.8%) - 1 (3.6%)
Sudden infant death syndrome (SIDS) - 3 4 - 1
Infant Deaths - Cause Unascertained - - - - -
Unexplained 2(5.7%) 2(5.0%) 1(2.7%) - -
No antecedents or associated obstetric factors - - - - -
Antecedents or associated obstetric factors present - - - - -
Very limited information available 2 2 - - -
Pending post mortem or other investigation - - 1 - -
Note: Data was missing for the following variables: gender not known for two cases, mode of delivery was not known for two cases and birthweight centiles 
could not be calculated for five cases.
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While not included in the calculation of 
perinatal mortality rates, we ask for notification 
of deaths in the early neonatal period of babies 
born before 24 weeks gestation and weighing 
less than 500g. For 2015, 35 such deaths 
were reported by 14 maternity units (Table 
7.1). This total of 35 deaths corresponds with 
the number of perinatal deaths of babies born 
before 24 weeks gestation with a birthweight 
less than 500g reported by maternity units 
to the Healthcare Pricing Office.  Twelve of the 
35 deaths occurred in babies born between 
22-23 weeks gestation and the remaining 23
deaths occurred in babies born between 16-
21 weeks gestation.
Using the NPEC Neonatal Classification 
System, the assigned cause of death was 
pre-viable (<22 weeks) for 22 cases (62.9%), 
severe pulmonary immaturity for 12 cases 
(34.3%) and one death was due to pulmonary 
hypoplasia. Based on the NPEC Maternal and 
Fetal Classification System, the antecedent or 
associated obstetric factors in these 35 early 
neonatal deaths were infection (n=19, 54.3%), 
spontaneous premature labour (n=11, 31.4%), 
maternal disorders (n=3, 8.6%), hypertensive 
disorders (n=1, 2.9%) and specific placental 
conditions (n=1, 2.9%).
The birthweights of the babies were in the 
range 93-485g and their gestation at delivery 
was 16-23 weeks. Customised birthweight 
centiles calculated for 34 of the 35 babies 
showed evidence of fetal growth restriction. 
Thirteen (38.2%) were small-for-gestational-
age (SGA; <10th centile), ten (29.4%) were 
severely SGA (<3rd centile).
All 35 babies died within 24 hours of being 
delivered, most commonly in the labour ward 
(n=20, 57.1%) but in some cases in another 
ward of the maternity unit (n=14, 40.0%) or 
neonatal unit (n=1, 2.9%). For 30 of the 35 
babies (85.7%), spontaneous respiratory 
activity was absent or ineffective at five 
minutes following delivery and for all but one 
(n=34, 97.1%) the heart rate was persistently 
less than 100 beats per minute. Only one 
case was offered active resuscitation in the 
delivery room.
An autopsy was performed in three cases 
(8.6%) and an autopsy was offered in a further 
13 cases. Placental histology examination 
was conducted following all but one of the 35 
deaths (97.1%).
7. Early neonatal deaths with a birthweight <500g and
a gestational age at delivery <24 weeks
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Gestational Birthweight Location Cause of Death Neonatal Autopsy Performed
age  of death (Yes/No)
(weeks)
16 104 Ward Pre-viable (<22 weeks) No
16 110 Labour Ward Pre-viable (<22 weeks) No
17 93 Ward Severe pulmonary immaturity No
18 - Labour Ward Pre-viable (<22 weeks) No
19 155 Ward Pre-viable (<22 weeks) No
19 220 Labour Ward Pre-viable (<22 weeks) No
19 240 Ward Pre-viable (<22 weeks) No
19 387 Ward Pre-viable (<22 weeks) No
20 309 Ward Pre-viable (<22 weeks) No
20 318 Labour Ward Pre-viable (<22 weeks) No
20 370 Ward Pre-viable (<22 weeks) No
20 380 Labour Ward Pre-viable (<22 weeks) No
20 382 Ward Pre-viable (<22 weeks) No
20 400 Ward Pre-viable (<22 weeks) No
20 420 Labour Ward Pre-viable (<22 weeks) No
21 340 Labour Ward Pre-viable (<22 weeks) No
21 340 Labour Ward Pre-viable (<22 weeks) No
21 395 Labour Ward Pre-viable (<22 weeks) No
21 450 Ward Pre-viable (<22 weeks) No
21 465 Labour Ward Pre-viable (<22 weeks) No
21 470 Labour Ward Pre-viable (<22 weeks) No
21 485 Labour Ward Pre-viable (<22 weeks) No
21 270 Ward Pre-viable (<22 weeks) Yes
22 365 Labour Ward Severe pulmonary immaturity No
22 380 Labour Ward Severe pulmonary immaturity No
22 420 Labour Ward Severe pulmonary immaturity No
22 424 Ward Severe pulmonary immaturity Yes
22 454 Labour Ward Severe pulmonary immaturity No
22 465 Labour Ward Severe pulmonary immaturity No
22 465 Ward Severe pulmonary immaturity No
22 480 Labour Ward Severe pulmonary immaturity No
22 485 Labour Ward Severe pulmonary immaturity No
22 485 Ward Severe pulmonary immaturity No
23 390 Labour Ward Severe pulmonary immaturity No
23 480 Neonatal Unit Pulmonary hypoplasia Yes
Note: Birthweight was unknown for one case. None of the above early neonatal deaths were coroner cases, unknown for one case.
Table 7.1: Early neonatal deaths in 2015 with a birthweight <500g and a gestational age at delivery <24 weeks
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Ms Bridget Boyd, Assistant Director of Midwifery, Coombe Women & Infants University Hospital 
Nominated by the Deputy Nursing Services Director, HSE
Dr Gerry Burke, Consultant Obstetrician & Gynaecologist, University Maternity Hospital Limerick 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Dr David Corcoran, Consultant Neonatologist, Rotunda Hospital 
Nominated by the Faculty of Paediatrics, RCPI
Dr Elizabeth Dunn, Consultant Obstetrician & Gynaecologist until 2016, Wexford General Hospital 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Dr Siobhan Gormally, Consultant Paediatrician, Our Lady of Lourdes Hospital 
Nominated by the Faculty of Paediatrics, RCPI
Ms Oonagh McDermott, Assistant Director of Midwifery, Sligo General Hospital 
Nominated by the Deputy Nursing Services Director, HSE
Dr Eoghan Mooney, Consultant Pathologist, National Maternity Hospital 
Nominated by the Faculty of Pathology, RCPI
Dr Keelin O’Donoghue, Consultant Obstetrician & Gynaecologist, Cork University Maternity Hospital 
Nominated by the Institute of Obstetricians & Gynaecologists, RCPI
Ms Breda O’Donovan, Clinical Midwife Manager III from 2017, University Hospital Waterford, 
Nominated by the National Lead Midwife Office of the Nursing & Midwifery Services Director
Ms. May Quirke, Assistant Director of Midwifery until 2016, Tralee General Hospital  
Nominated by Elizabeth Adams, Deputy Nursing Services Director, HSE (Ms. Maudie Creagh, Tralee General Hospital 
Nominated by May Quirke to attend in her absence) 
Ms Ann Rath, Clinical Midwife Manager III, National Maternity Hospital 
Nominated by the Deputy Nursing Services Director, HSE
Dr Anne Twomey, Consultant Neonatologist, National Maternity Hospital 
Nominated by the Faculty of Paediatrics, RCPI
Ms Patricia Williamson, Assistant Director of Midwifery, Rotunda Hospital 
Nominated by the Deputy Nursing Services Director, HSE
Prof Richard Greene, Consultant Obstetrician & Gynaecologist, Cork University Maternity Hospital 
Chair, Director of the National Perinatal Epidemiology Centre
Ms Edel Manning, Research Midwife, National Perinatal Epidemiology Centre 
Perinatal Mortality Project Manager
Mr Paul Corcoran PhD, Senior Lecturer in Perinatal Epidemiology, National Perinatal Epidemiology Centre 
National Perinatal Epidemiology Centre contributor
Ms Sarah Meaney, Research Officer, National Perinatal Epidemiology Centre
National Perinatal Epidemiology Centre contributor
Appendix A: Perinatal Mortality Group members
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Appendix B: Endorsement by the National Office of 
Clinical Audit (NOCA) 
 
 
National Office of Clinical Audit, 2nd Floor, Ardilaun House, 111 St Stephen’s Green, Dublin 2   Tel: + (353) 1 4028577                        
 
 
 
 
 
 
 
Professor Richard A. Greene 
Director 
National Perinatal Epidemiology Centre 
5th Floor, Cork University Maternity Hospital 
Wilton 
Cork 
          27th February 2017 
 
Perinatal Mortality in Ireland, Annual Report 2015 
 
Dear Professor Greene, 
 
I write to thank you and your colleague Dr Paul Corcoran for your detailed presentation to the NOCA 
Governance Board, 23rd February 2017 of NPEC’s Perinatal Mortality in Ireland – Annual Report 2015. 
  
You and your NPEC colleagues are to be congratulated for the quality of the report and manner in 
which you continue to engage with maternity services to maintain this work.   
 
The NOCA Board and Executive Team will continue to support NPEC governance efforts and in 
particular highlight the national requirement for resource commitment to ensure sustainable clinical 
audit of perinatal and maternal outcomes. 
 
Please accept this as formal endorsement from the NOCA Governance Board of the Perinatal 
Mortality in Ireland Annual Report 2015. 
 
 
Yours sincerely, 
 
 
 
 
Professor Conor O’ Keane FFPath FRCPI 
Chair 
National Office of Clinical Audit Governance Board 
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Appendix C: Hospital Co-ordinators and Contributors 2015
Cavan General Hospital Dr Rukhsana Majeed
Ms Evelyn McAdam
Ms Karen Malocca
Coombe Women and Infants University 
Hospital, Dublin
Dr Naomi Burke
Dr Anna Durand O Connor
Dr Sharon Sheehan
Cork University Maternity Hospital Dr Keelin O’Donoghue 
Ms Claire Everard
Ms Siobhan Bourke
Dr Brendan Murphy 
Ms Linda Dawson
University Hospital Kerry Ms Mary Stack Courtney
Letterkenny University Hospital Ms Mary Lynch Ms Evelyn Smith
Mayo University Hospital Ms Pauline Corcoran 
Ms Diane Brady
Dr Hilary Ikele
Dr Meabh Ní Bhuinneain
Midland Regional Hospital Mullingar Ms Marie Corbett
Midland Regional Hospital Portlaoise Ms Emma Mullins
Ms Ita Kinsella
University Maternity Hospital Limerick Ms Sandra O’Connor,
Ms Margo Dunworth
Dr Gerry Burke
Dr Roy Philip
National Maternity Hospital, Dublin Ms Fionnuala Byrne Dr Eoghan Mooney
Dr Anne Twomey
Dr Rhona Mahony 
Our Lady of Lourdes Hospital, Drogheda Ms Siobhan Weldon
Ms Sinead Dow 
Ms Fiona Mulligan 
Dr Seosamh Ó Cóigligh
Portiuncula Hospital, Ms Priscilla Neilan
Ms Karen Leonard
Rotunda Hospital, Dublin Ms Ruth Ritchie Dr Sam Coulter Smith
Sligo University Hospital Ms Madeline Munnelly
Ms Juliana Henry
Dr Heather Langan
South Tipperary General Hospital, 
Clonmel
Ms Siobhan Kavanagh
St Luke’s Hospital, Kilkenny Ms Connie McDonagh
University Hospital Galway Ms Marie Hession
University Hospital Waterford Ms Margaret Coe 
Ms Emer Denn
Ms Paula Curtain
Wexford General Hospital Ms Helen McLoughlin
HOSPITAL CO-ORDINATORS ADDITIONAL CONTRIBUTORS
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Chair: Dr. Michael Robson, Consultant Obstetrician and Gynaecologist, National Maternity Hospital
Dr. Michael Brassil, Consultant Obstetrician and Gynaecologist, Portiuncula Hospital
Professor Tom Clarke, Consultant Neonatologist, Rotunda Hospital
Dr Sharon Cooley, Consultant Obstetrician and Gynaecologist, Institute of Obstetrics and Gynaecology 
Representative 
Dr Sam Coulter-Smith, until 2016, Master, Rotunda Hospital
Ms. Marie Cregan, University College Cork - Patient Representative
Professor Declan Devane, Chair of Midwifery, National University of Ireland, Galway
Dr. Geraldine Gaffney, Senior Lecturer, National University of Ireland, Galway
Professor Richard Greene, Consultant Obstetrician & Gynaecologist, Cork University Maternity Hospital, Director of 
the National Perinatal Epidemiology Centre
Ms Fiona Hammond Cahill, until 2016, NOCA Executive Director, National Office of Clinical Audit
Ms Ann Keating¸ Clinical Midwife Manager II, until 2015, Our Lady of Lourdes Hospital
Dr. Heather Langan, Consultant Obstetrician and Gynaecologist, Sligo General Hospital
Dr. Rhona Mahony, Master, The National Maternity Hospital
Professor Fergal Malone, Master, The Rotunda Hospital
Dr. Eleanor Molloy, Consultant Neonatologist, National Maternity Hospital
Professor Deirdre Murphy, Chair in Obstetrics, Trinity Centre for Health Sciences, St. James Hospital
Ms. Connie McDonagh, Clinical Midwife Manager III, St. Luke’s General Hospital
Dr. Mary O’Mahony, Specialist in Public Health Medicine, HSE
Dr. Sharon Sheehan, Master, Coombe Women and Infants University Hospital
Ms Sheila Sugrue, National Lead Midwife, Office of the Nursing & Midwifery Services 
Ms Collette Tully, NOCA Executive Director, National Office of Clinical Audit
Ms Michelle Waldron, Chair of the national Designated Midwifery Officer Group - Home Births
Appendix D: NPEC Governance Committee
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Appendix E: Perinatal Death Notification Form 2015
1 
 
 
  
 
PERINATAL DEATH NOTIFICATION FORM 
2015  
 
CHOOSE Type of Case (TICK) 
  STILLBIRTH: A baby delivered without signs of life from 24 weeks’ gestation and/or with a birth weight of ≥ 
500g. 
 
 *If the birth occurred unattended and there was no lung aeration seen at Post Mortem (PM) and no other 
circumstantial evidence of life at birth, it should be assumed that the baby was stillborn.  
 
 
OR 
 EARLY NEONATAL DEATH: Death of a live born baby occurring before 7 completed days after birth. 
 
OR 
 LATE NEONATAL DEATH:  Death of a live born baby occurring from the 7th day and before 28 completed 
days after birth. 
 
 
* For the purpose of reporting, a ‘live born’ baby is defined as any baby born with evidence of life such as  
breathing movements, presence of a heart beat, pulsation of the cord or definite movement of voluntary 
muscles.   
 
  *If a baby born at <22 completed weeks is being registered as a neonatal death, please report same to 
NPEC. 
 
 
 
 
 
 
 
The National Perinatal Epidemiology Centre is sincerely grateful for your contribution to this 
audit. 
 
Guidance for completing this form, with specific reference to Sections 11, 12 and 13 on Cause 
of Death, is outlined in the accompanying reference manual. 
 
The National Perinatal Epidemiology Centre also acknowledges with thanks the Centre for Maternal and Child 
Enquiry (CMACE) UK for permission to modify and use its Perinatal Mortality Notification Proforma for use in the 
Irish context.  
 
For NPEC Office use only:  
CASE NUMBER  
 
PLACE OF DEATH: 
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2 
SECTION 1.  WOMANS’ DETAILS  
       1.1. Mother’s age   
1.2. Ethnic group: 
     White - Irish                               Irish Traveller  
            Any other White background         Please specify country of origin ______________________________________  
      Asian or Asian Irish                    Black or Black Irish    
     Other including mixed ethnic backgrounds: Please specify  ______________________________________________      
            Not recorded 
         
        1.3. What was the woman’s occupation at booking? 
 
 ___________________________________________________________________________________________________   
 
1.4. What was the occupation of the woman’s partner at booking?                     
 
                ___________________________________________________________________________________________________  
 
 1.5. Level of education completed by this woman: 
        Primary or less      Secondary                Third Level               Unknown   
 1.6. Height at booking (round up to the nearest cm):  
 1.7. Weight at booking (round up to the nearest kg):    
 If weight is unavailable, was there evidence that the woman was too heavy for hospital scales?  Yes  No 
 1.8. Body Mass Index at booking (BMI):  . 
 
 1.9.a. Did the woman smoke at booking?      Yes, specify quantity smoked per day__________________ 
                               No                     Unknown 
 1.9.b. Did she give up smoking during pregnancy?             Yes             No          Unknown     N/A 
 
 1.10. Is there documented history of alcohol abuse?  
        None recorded                  Prior to this pregnancy                  During this pregnancy  
 
           
       1.11. Is there documented history of drug abuse or attendance at a drug rehabilitation unit?  
              None recorded                  Prior to this pregnancy                  During this pregnancy  
SECTION 2.  PREVIOUS PREGNANCIES  
2.1. Did the woman have any previous pregnancies?    If yes, please complete questions 2.2-2.4                 Yes        No 
2.2. No. of completed pregnancies ≥24 weeks and or with a birth weight ≥ 500g (all live and stillbirths):   
2.3. No. of pregnancies <24 weeks and with a birth weight < 500g:         
72  PERINATAL MORTALIT Y IN IREL AND ANNUAL REPORT 2015 
3 
2.4. Were there any previous pregnancy problems? If yes, please tick all that apply below  Yes  No 
       Three or more miscarriages  Pre-term birth or mid trimester loss         Stillbirth, please specify number   
       Infant requiring intensive care    Baby with congenital anomaly              Neonatal death, please specify number   
Previous caesarean section Placenta praevia               Placental abruption      
Pre-eclampsia (hypertension &  proteinuria)          Post-partum haemorrhage requiring transfusion 
Other, please specify_______________________________________   Unknown 
 
 
SECTION 3.  PREVIOUS MEDICAL HISTORY 
3.1. Were there any pre-existing medical problems? If yes, please  tick all that apply below    Yes  No Unknown 
Cardiac disease (congenital or acquired)  Epilepsy  
Endocrine disorders e.g. hypo or hyperthyroidism  Renal disease 
Haematological disorders e.g. sickle cell disease       Psychiatric disorders 
Inflammatory disorders e.g. inflammatory bowel disease  Hypertension  
Diabetes  Other, please specify  ________________________  
 
 
SECTION 4.  THIS PREGNANCY 
4.1. Final Estimated Date of Delivery (EDD):      //      Unknown 
  Use best estimate (ultrasound scan or date of last menstrual period) based on a 40 week gestation, or the final date agreed 
in the notes. 
4.2. Was this a multiple pregnancy at the onset of pregnancy?             Yes       No 
 
4.3. Was this pregnancy a result of infertility treatment?                          Yes     No             Unknown 
 
               If yes, please specify method of fertility treatment _______________________________________________________________ 
  
       4.4 Gestation at first booking appointment:        weeks + days               Not booked         Unknown  
 
 4.5 Intended place of delivery at booking:  Name of unit _________________________________ 
 
Please specify the type of unit  
  Obstetric Unit      Alongside Midwifery Unit               Home                   Unbooked 
 
 4.6 What was the intended type of delivery care at booking?  
         Obstetric-Led Care         Midwifery-Led Care            Self-Employed Community Midwife      
         Home c/o Hospital DOMINO Scheme 
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SECTION 5.  DELIVERY 
      
       5.1. Onset of labour: 
 Spontaneous          Induced  Never in labour  
 
5.2. Intended place of delivery at onset of labour:  Name of unit ____________________________ 
  
Please specify the type of unit 
 Obstetric Unit    Alongside Midwifery Unit     Home 
       
       5.3. What was the intended type of care at onset of labour?  
 Obstetric-Led Care         Midwifery-Led Care            Self-Employed Community Midwife      
 Home c/o Hospital DOMINO Scheme 
 
5.4. Was the intended mode of delivery a planned caesarean section?    Yes    No  
 
5.5. Place of delivery: Name of unit ____________________________________  
 
Please specify the type of unit 
  Obstetric Unit             Alongside Midwifery Unit                         Home 
 
5.6. What was the type of care at delivery?  
 Obstetric-Led Care        Midwifery -Led Care              Born Before Arrival (BBA) - Unattended      
 Self-Employed Community Midwife       Home c/o Hospital DOMINO Scheme                             
       5.7. Date and time of delivery/birth:  Date: //       Time:: 
 
5.8. What was the presentation at full dilation?  
Vertex  Breech  Compound (includes transverse and shoulder presentations)  Brow  Face    
5.9. What was the presentation at delivery?  
Vertex  Breech  Compound (includes transverse and shoulder presentations) Brow  Face    
 
5.10. What was the mode of delivery? (Please tick all that apply) 
Spontaneous Vaginal     Ventouse           Lift-Out Forceps        Mid-Cavity Forceps        Rotational Forceps         
Assisted Breech delivery         Pre-Labour Caesarean Section                 Caesarean Section After Onset of Labour 
 
 
 
CAESAREAN SECTIONS ONLY 
 
5.11. What was the type of or indication for Caesarean Section? 
Elective - At a time to suit woman or maternity team Urgent - Maternal or fetal compromise which is not immediately life threatening    
Emergency - Immediate threat to life of woman or fetus          Failed instrumental delivery 
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5 
SECTION 6.  ALL BABY OUTCOME 
      6.1. Sex of fetus/baby:     Male    Female     Indeterminate  
      6.2. Number of fetuses/babies in this delivery: (all identifiable including papyraceous)                   
             Birth order of this fetus/baby:   
Singleton  
 Twin 1  Twin 2   
 Triplet 1  Triplet 2                 Triplet 3  
Other multiple birth pregnancy, please specify__________         Birth Order   
       
        6.3. If from a multiple delivery, what was the chorionicity? Please tick all that apply 
Dichorionic diamniotic  Monochorionic diamniotic   Monochorionic monoamniotic Trichorionic   Not known 
       
        6.4. Birth weight (kg):  .  
 6.5. Gestation at delivery:  weeks + days                        Unknown 
       6.6. Was this a termination of pregnancy?   Yes  No 
              Please refer to the reference manual, page 2   
 
       6.7. Was a local hospital review of this case undertaken?      Yes  No 
 
 
 
SECTION 7. MATERNAL OUTCOME 
       7.1. Admission to HDU:                                                                                                                           Yes    No  
       7.2. Admission to ICU:                                                                                                                             Yes    No  
       7.3. Maternal Death:                                                                                                                                 Yes    No 
 
 
   
SECTION 8. STILLBIRTH (If not a stillbirth, please go to Section 9) 
      8.1. At what gestation was death confirmed to have occurred?  weeks + days  
      If known, what date was death confirmed?  // 
 
      8.2. Was the baby alive at onset of care in labour?   
Yes                    No                Never In Labour                    Unattended       Unknown 
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SECTION 9. NEONATAL DEATH ONLY 
       9.1. Was spontaneous respiratory activity absent or ineffective at 5 minutes?    Yes  No 
If a baby is receiving any artificial ventilation at 5 minutes, the assumption is absent/ineffective activity: a 0 Apgar score indicates 
absent activity.  
 
 
       9.2. Was the heart rate persistently <100bpm? ( i.e. heart rate never rose above 100bpm before death)  
                                                  Persistently <100bpm Rose above 100bpm 
      
       9.3. Was the baby offered *active resuscitation in the delivery room?                                             Yes  No 
        (*active resuscitation includes BMV, PPV, intubation, cardiac massage) 
 
 
        9.4. Was the baby admitted to a neonatal unit? (Includes SCBU and ICU)                                          Yes  No 
        9.5. Was the baby transferred to another unit after birth?                                                                   Yes  No 
   
        9.6. Date and Time of Death:                                                Date //       Time : 
 
        9.7. Place of Death*:            Labour Ward               Neonatal Unit                 Ward          
                                                In Transit                     Paediatric Centre           Home     
 
                                                           Name of unit:_____________________________________________ 
 
*This question refers to where the baby actually died, e.g. ‘ICU, ‘at home’ or ‘in transit’. 
 Babies are deemed to have died ‘at home’ if there are no signs of life documented in the home even if resuscitation is attempted. 
 A baby is deemed to have died ‘in transit’ if signs of life are documented prior to transfer but the baby was either declared dead on arrival to  
the hospital or showed no subsequent signs of life in the hospital, despite attempted resuscitation.. 
  
SECTION 10. POST-MORTEM  
       10.1. Was this a coroner’s case? If yes, please complete question 10.2.                                                   Yes   No  
10.2. Has the post-mortem report been received from the coroner’s office?                                   Yes   No 
         If no, please complete question 10.3.                                      
                                                                                                               
       10.3. Please specify which coroner’s jurisdiction this case was assigned to: _____________________________ 
                                            
 
 
10.4. Was a post-mortem performed?                                                                                   Yes  No 
         If no, please complete question 10.5. 
10.5. Was a  post-mortem offered?                                                                                        Yes  No 
 
10.6. Were any of the following procedures carried out after death?  
               Please tick all that apply    
         MRI                      X-Ray                  CT                    External Examination           
  
 
      10.7. Was the placenta sent for histology?                                                                                         Yes  No 
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SECTION 11. CAUSE OF DEATH AND ASSOCIATED FACTORS - STILLBIRTH & NEONATAL DEATH  
 
  11. Please TICK ALL the maternal or fetal conditions that were present during pregnancy or were  
associated with the death.  PLEASE REFER TO THE REFERENCE  MANUAL. 
 
        11.1.1. MAJOR CONGENITAL ANOMALY:   
 
Central nervous system         Cardiovascular system      Respiratory system  Gastro-intestinal system    
Musculo-skeletal anomalies   Multiple anomalies          Urinary tract        Metabolic diseases      
 
 Other major congenital anomaly, please specify ________________________________________________________________ 
 
 Chromosomal disorder*, please specify ________________________________________________________________ 
      
* In the event of a chromosomal disorder how was the diagnosis made? 
 
   Clinically                               Cytogenetic analysis *                  Ultrasound                 
                                                      *See reference manual, page 2 
 
        11.1.2. HYPERTENSIVE DISORDERS OF PREGNANCY: 
 
Pregnancy induced hypertension    Pre-eclampsia  HELLP syndrome     Eclampsia  
 
        11.1.3. ANTEPARTUM or INTRAPARTUM HAEMORRHAGE:    
 
Praevia   Abruption   Cause uncertain 
 
        11.1.4. MECHANICAL:    
 
Cord compression:  Prolapse cord  Cord around neck    Other cord entanglement or knot 
Uterine rupture: Before labour During labour 
Mal-presentation: Breech                     Face  Compound  
 Transverse Other, please specify  ___________________________________  
        Shoulder dystocia:  
 
        11.1.5. MATERNAL DISORDER:       
    Pre-existing hypertensive disease   Diabetes     Other endocrine conditions (excluding diabetes)        
    Thrombophilias   Obstetric cholestasis  Uterine anomalies                       
    Connective tissue disorders, please specify______________________________________________________________________________ 
    Other, please specify_______________________________________________________________________________________________ 
 
        11.1.6. INFECTION: (confirmed by microbiology/placental histology)   
 
Maternal infection:  Bacterial    Syphilis    Viral diseases    
 Protozoal                                        Group B Streptococcus 
                                Other, please specify organism  _______________________________________________________ 
Ascending infection: 
                                                         Chorioamnionitis    Other, please specify  _________________________________ 
 
        11.1.7. SPECIFIC FETAL CONDITIONS:    
Twin-twin transfusion       Feto-maternal haemorrhage    Non-immune hydrops    Iso-immunisation    
Other, please specify _________________________________________________________________________________________________  
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        11.1.8. SPECIFIC PLACENTAL CONDITIONS:   
 
No abnormal histology reported 
Vasa praevia      Velamentous insertion                             Massive perivillous fibrin deposition   
Placental infarction           ĺ           Please specify approximate percentage involved _______________ 
       Chorioamnionitis              ĺ           Mild                             Moderate                          Severe 
       Fetal vasculitis             ĺ          Arterial                    Venous                        Both      
Retroplacental haemorrhage    ĺ    Please specify approximate percentage of maternal surface involved _______________ 
Thrombosis in fetal circulation   ĺ   Please specify if arterial or venous _______________ 
       Villitis                     ĺ                      Mild                             Moderate                         Severe 
Other, please specify_______________________________________________________________________________________________ 
 
        11.1.9. INTRA-UTERINE GROWTH RESTRICTION DIAGNOSIS MADE:     YES   
         
          What was this based on? Please tick all that apply 
 Suspected antenatally                    Observed at delivery                         Observed at post-mortem      
        11.1.10. ASSOCIATED OBSTETRIC FACTORS: Please tick all that apply   
        Birth trauma             Intracranial haemorrhage                         Subgaleal haematoma    
                                  Fracture, please specify_____________________________________________________ 
                                  Other, please specify________________________________________________________________________________ 
 Intrapartum fetal blood sample result < 7.25       Yes     No 
 
      Polyhydramnios                  Oligohydramnios            Premature rupture of membranes     
      Prolonged rupture of membranes (> 24hours)                Amniocentesis                             
   Spontaneous premature labour                 Other, please specify_____________________________________________________   
 
       11.1.11. NO ANTECEDENT OR ASSOCIATED OBSTETRIC FACTORS:       
  
 
 
 
 
 
 
 
 
  
        11.1.12. UNCLASSIFIED: Please use this category as sparingly as possible   
 
SECTION 12.  MAIN CAUSE OF DEATH: STILL BIRTH & NEONATAL DEATHS 
 
     12.1. Which condition, indicated in Section 11 as being present, was the MAIN condition or sentinel event          
causing or associated with the death.  Please refer to the post-mortem and placental histology reports.   
        (NB “non-MAIN” conditions are best described as the “Other clinically relevant maternal or fetal conditions/ factors that were associated 
with but not necessarily causing the death”).   
 
 
 
 
 
 
 
 
   12.2. Was the cause of death question completed using a placental histology report or a post-mortem report?  
               Please tick all that apply  
                 Post Mortem             Placental Histology              Both              Neither 
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SECTION 13. NEONATAL DEATH ONLY:  NEONATAL CONDITIONS ASSOCIATED WITH THE DEATH 
 
 
       13.1. Please TICK ALL the neonatal conditions causing and associated with the death.  
                PLEASE REFER TO THE REFERENCE  MANUAL. 
 
        13.1.1. MAJOR CONGENITAL ANOMALY:   
 
Central nervous system         Cardiovascular system      Respiratory system  Gastro-intestinal system    
Musculo-skeletal anomalies   Multiple anomalies          Urinary tract        Metabolic diseases                              
  
Other major malformation, please specify ________________________________________________________________ 
 
 
Chromosomal disorder*, please specify ________________________________________________________________ 
      
* In the event of a chromosomal disorder how was the diagnosis made? 
 
   Clinically                                     Cytogenetic analysis *                  Ultrasound                 
                                                              *See reference manual 
 
        13.1.2. PRE-VIABLE: (less than 22 weeks)           
 
        13.1.3. RESPIRATORY DISORDERS:    
 
   Severe pulmonary immaturity    Surfactant deficiency lung disease Pulmonary hypoplasia Meconium aspiration syndrome    
 
   Primary persistent pulm. hypertension          Chronic lung disease / Bronchopulmonary dysplasia (BPD)   
   Other (includes pulmonary haemorrhage), please specify____________________________________________________________________ 
 
 
 
        13.1.4. GASTRO-INTESTINAL DISEASE:    
 
Necrotising enterocolitis (NEC)    Other, please specify __________________________________________________________________ 
 
 
        13.1.5. NEUROLOGICAL DISORDER:   
 
Hypoxic-ischaemic encephalopathy (HIE)                                                  
 
*Intraventricular / Periventricular haemorrhage, please specify highest grade (0 – 4) *           
    Hydrocephalus*,  please tick all that apply: 
                   * Congenital              Acquired                     Communicating                   Obstructive       Other__________________            
 
 
Other, please specify______________________________________________________________________________________________ 
 
 
        13.1.6. INFECTION:   
 
Generalised (sepsis)     Pneumonia      Meningitis       
Other, specify ______________ 
 
 
        13.1.7. INJURY / TRAUMA: (Postnatal)     
  
 
             Please specify_______________________________________________________________________________________________________ 
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        13.1.8. OTHER SPECIFIC CAUSES:   
 
Malignancies / Tumours              In-born errors of metabolism, please specify ___________________________________ 
Specific conditions, please specify___________________________________________________________________________ 
 
 
        13.1.9. SUDDEN UNEXPECTED DEATHS:   
 
Sudden Infant Death Syndrome (SIDS)        Infant death – Cause unascertained 
 
        13.1.10. UNCLASSIFIED: (Use this category as sparingly as possible)   
 
 
      13.2. Which condition, indicated in Section 13.1 as being present, was the MAIN condition causing or 
associated with the death.  Please refer to the post-mortem report.  In the absence of a post-mortem report, please 
refer to the death certificate.  
        (NB “non-MAIN” conditions are best described as the “Other clinically relevant maternal or fetal conditions/ factors that were associated 
with but not necessarily causing the death”).   
 
 
 
 
 
 
  
 
     
      13.3. Was the cause of death question completed using a placental histology or a post-mortem report?  
                Please tick all that apply  
              
 
            Post Mortem             Placental Histology              Both              Neither 
 
 
 
 
SECTION 14. DETAILS OF REPORTING UNIT (Please print) 
        
   14.1. Name of reporting unit: ______________________________________________________________________ 
       14.2. Completed by 
          Name: _________________________________________________________________________________________ 
          Staff Grade: ____________________________________________________________________________________ 
          Work address: __________________________________________________________________________________ 
          _______________________________________________________________________________________________ 
          Telephone Number: _____________________ 
          E-mail Address:_________________________ 
          Date of Notification: // 
 
 
 
Thank you very much for taking the time to complete this form 
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Appendix F: Terminology for placental pathology44
PATHOLOGY CATEGORY SPECIFIC PLACENTAL FINDINGS
Maternal vascular malperfusion Refers to the spectrum of fi ndings related to shallow implantation of 
 the placenta, often found in conjunction with PET and IUGR and often  
 called utero placental insuffi ciency. Placental fi ndings that enable this 
 category to be applied are: 
 distal villous hypoplasia 
 accelerated villous maturation
 ischaemic villous crowding
 placental infarction 
 retroplacental haemorrhage 
 placental hypoplasia
Fetal vascular malperfusion Refers to thrombosis or decreased fl ow in the fetal circulation. It may be 
 diffi cult to distinguish arteries from veins in the placenta and pathology 
 may be present in both. Findings consistent with fetal vascular 
 malperfusion are:
 patchy hypoperfusion 
 villous stromal-vascular karyorrhexis             
 scattered avascular villi         
 thrombosis in fetal circulation    
 fetal thrombotic vasculopathy / extensive avascular villi
Cord pathology Cord pathology may exist by itself, or may be accompanied by evidence  
 of other disease. The fi ndings of cord pathology include:
 hypercoiled cord (Umbilical coiling index (UCI) of ≥ 0.3)
 cord stricture               
 hypocoiled cord  (UCI < 0.1)                          
 meconium associated vascular necrosis                       
 velamentous or marginal (<10mm) cord insertion             
 Other     
Delayed villous maturation Delayed villous maturation is the recommended term instead of distal  
 villous immaturity, placental maturation defect or villous maturation 
 defect.
Chorioamnionitis The maternal and fetal infl ammatory response should be staged and   
 graded where possible. 
Villitis The term is used to mean villitis of unknown aetiology and assumes 
 that the reporting pathologist has excluded infection where appropriate. 
 Villitis is graded as either low grade or high grade and can occur with 
 stem vessel obliteration.
Other 
44 Khong TY, Mooney EE et al: Sampling and defi nition of placental lesions. Arch Pathol Lab Med.
Note: More than one placental category may be present.
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Guidance and Definitions for Completion of Section 11 & 12 
STILLBIRTH AND NEONATAL DEATH 
 
DEFINITION OF TERMS Subcategory 
1. MAJOR CONGENITAL ANOMALY. Any genetic or structural defect arising at conception or 
during embryogenesis incompatible with life or potentially treatable but causing death 
 
Central nervous system    
Cardiovascular system 
Respiratory system  
Gastro-intestinal system  
Musculo-skeletal anomalies 
Multiple anomalies   
Chromosomal disorders 
Metabolic diseases  
Urinary tract 
Other 
2. HYPERTENSIVE DISORDERS OF PREGNANCY. 
 
Pregnancy induced hypertension 
Pre-eclampsia 
HELLP syndrome 
Eclampsia  
3. ANTEPARTUM OR INTRAPARTUM HAEMORRHAGE. After 20 w gestation, whether 
revealed or not. If associated with PET, APH will be a secondary diagnosis. Ignore minor degrees 
of haemorrhage (e.g. ‘shows’, cervical polyps etc). Recurrent bleeding of uncertain origin followed 
by preterm labour should not be ignored. 
Praevia 
Abruption 
Uncertain 
 
4. MECHANICAL. Any death attributed to uterine rupture, deaths from birth trauma or intrapartum 
asphyxia associated with problems in labour such as cord compression, malpresentation, 
shoulder dystocia etc. 
Antepartum deaths associated with cord entanglement in the absence of strong circumstantial          
evidence that cord compression caused death should be classified as having no associated 
factor. 
 
Cord Compression  
Prolapse cord  
Cord around neck 
Other cord entanglement or knot 
Uterine Rupture  
Before labour 
During labour 
Mal-presentation 
Breech / Transverse   
       Face / Compound 
Other  
Shoulder dystocia 
5. MATERNAL DISORDER. Specify hypertensive disease present before pregnancy or any 
other maternal disease or condition sufficient to jeopardise the baby such as diabetes, cardiac 
disease etc.  
Infection is classified separately. 
 
Pre-existing hypertensive disease  
Diabetes  
Other endocrine conditions 
Thrombophilias   
Obstetric cholestasis   
Drug misuse    
Uterine anomalies 
Connective tissue disorders / Other  
6. INFECTION. Confirmed by microbiology / placental histology. 
Specify maternal infections sufficient to have compromised the baby which may be associated 
with      congenital infection of the baby. Trans-placental transmission may have occurred such as 
CMV, toxoplasmosis etc.  
Specify only those ascending infections that are a significant factor in death. Chorioamnionitis 
sufficient to cause preterm birth may be specified for some neonates but evidence of fetal 
infection may be required as an explanation of stillbirth.  
Maternal infection 
Bacterial / Viral diseases  
Syphilis  /Group B Streptoccus  
Protozoal 
Other 
Ascending infection  
Chorioamnionitis 
Other 
7. SPECIFIC FETAL CONDTIONS. Document only those specific conditions arising in the fetal 
period. 
 
 
Twin-twin transfusion   
Feto-maternal haemorrhage 
Non-immune hydrops 
Iso-immunisation 
Other 
8. SPECIFIC PLACENTAL CONDITIONS. Specific placental conditions sufficient to cause 
death or be associated with fetal compromise such as IUGR. These will often be secondary to 
other maternal conditions e.g. PET. 
Cord problems associated with compression will normally be classified under ‘Mechanical’ 
Placental infarction   
Retroplacental haemorrhage         
Thrombosis in fetal circulation 
Chorioamnionitis 
Vilitis  
Fetal vasculitis 
Massive perivillous fibrin deposition 
Vasa praevia / Velementous insertion 
Other 
9. INTRA-UTERINE GROWTH RESTRICTION DIAGNOSIS MADE. IUGR may be 
suspected antenatally by abdominal circumference (AC) less than the centile threshold used to 
define IUGR locally, or decreased AC growth velocity, +/- oligohydramnios. 
Suspected antenatally 
Observed at delivery 
Observed at post mortem 
10. ASSOCIATED OBSTETRIC FACTORS. Factors recorded as Other Associated Obstetric 
Factors will be important clinical or pathological features of the pregnancy or baby but will not be 
an explanation of the death; they will often be secondary to other maternal or fetal conditions. 
Birth trauma and/or Intrapartum asphyxia should normally be classified primarily by the underlying 
cause (e.g Mechanical ). Birth Trauma and/or other antenatal/intra-partum factors can be 
recorded here either as a secondary factor or when there is no underlying explanation. 
 
 
Birth Trauma 
Intracranial haemorrhage 
Birth injury to scalp 
Fracture 
Other 
Intrapartum fetal blood 
sample <7.25 
Other 
Polyhydramnios 
Oligohydramnios 
Premature rupture of membranes 
Spontaneous premature labour 
4 
 
Other 
11. NO ANTECEDENT OR ASSOCIATED OBSTETRIC FACTORS. Deaths with no 
explanation or significant associated factor. 
 
12. UNCLASSIFIED.  Cases where little or nothing is known about pregnancy or delivery and 
which cannot be fitted into any of the above categories. Use as sparingly as possible.  
 
 
 
 
 
 
 
 
 
Guidance and Definitions for Completion of Section 13: 
NEONATAL DEATH ONLY 
 
The following definitions and associated subcategories will help you choose the relevant 
neonatal conditions causing and associated with death 
 
DEFINITION OF TERMS Subcategory 
MAJOR CONGENITAL ANOMALY. Any genetic or structural defect arising at conception or 
during embryogenesis incompatible with life or potentially treatable but causing death. 
Central nervous system 
Cardiovascular system 
Respiratory system 
Gastro-intestinal system 
Musculo-skeletal system 
Multiple anomalies 
Chromosomal disorders 
Metabolic disorders  
Urinary tract  
Other 
PRE-VIABLE. Babies (less than 22 weeks) who are non-viable at birth because of gestation but 
who show signs of life. 
 
RESPIRATORY DISORDERS. Severe pulmonary immaturity will encompass those babies 
where structural lung immaturity is so gross as to mean ventilatory support is unsustainable at the 
outset, usually babies between 22 – 24w gestation. Surfactant Deficient Lung Disease may 
include babies with clinical or pathological evidence of hyaline membrane disease.  
Severe pulmonary immaturity 
Surfactant deficiency lung disease 
Pulmonary hypoplasia 
Meconium aspiration syndrome 
Primary persistent pulmonary hypertension 
Chronic lung disease / BPD 
Other (includes pulmonary haemorrhage) 
GASTRO-INTESTINAL DISEASE. Many babies with NEC will have associated sepsis which 
may be given as a secondary cause.  
Necrotising enterocolitis (NEC) 
Other 
NEUROLOGICAL DISORDER. HIE includes those babies with severe hypoxic-ischaemic 
brain injury before birth. If possible, please specify if HIE was primarily of intrapartum or 
antepartum origin. Specify periventricular leukomalacia only if this is a significant factor in the 
infant death. Birth Trauma will usually be classified here.  
Hypoxic-ischaemic encephalopathy (HIE) 
Intraventricular/Periventricular haemorrhage 
Other 
 
INFECTION. Where possible specify the location of infection and whether due to bacteria, virus, 
fungus or other specific organism.   
If infection was the main cause of death please specify whether infection is congenital (i.e. 
acquired ante or intrapartum acquired) or neonatal in origin. 
Generalised (sepsis) 
Pneumonia 
Meningitis 
Other 
 
INJURY / TRAUMA. Post natal trauma only including iatrogenic injury. ‘Birth Trauma’ will 
usually be classified under neurological disorder e.g. HIE; the obstetric classification identifying 
the timing of the injury.  
 
OTHER SPECIFIC CAUSES. Death due to specific fetal and neonatal conditions such as 
isoimmunisation or unexplained hydrops. Neonatal conditions will include aspiration, unexplained 
pulmonary haemorrhage.  
Malignancies/Tumours 
Specific conditions 
SUDDEN UNEXPECTED DEATHS. SIDS should conform to the accepted definition. 
Unascertained are those unexpected deaths that are not explained despite a full investigation 
including autopsy, but do not conform to the accepted definition of SIDS. 
Sudden Infant Death Syndrome (SIDS) 
Infant deaths – cause unascertained 
UNCLASSIFIED.  Cases where little or nothing is known about the pregnancy or delivery and 
which cannot be fitted into any of the above categories. Please use this category as sparingly as 
possible.  
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Other 
11. NO ANTECEDENT OR ASSOCIATED OBSTETRIC FACTORS. Deaths with no 
explanation or significant associated factor. 
 
12. UNCLASSIFIED.  Cases where little or nothing is known about pregnancy or delivery and 
which cannot be fitted into any of the above categories. Use as sparingly as possible.  
 
 
 
 
 
 
 
 
 
Guidance and Definitions for Completion of Section 13: 
NEONATAL DEATH ONLY 
 
The following definitions and associated subcategories will help you choose the relevant 
neonatal conditions causing and associated with death 
 
DEFINITION OF TERMS Subcategory 
MAJOR CONGENITAL ANOMALY. Any genetic or structural defect arising at conception or 
during embryogenesis incompatible with life or potentially treatable but causing death. 
Central nervous system 
Cardiovascular system 
Respiratory system 
Gastro-intestinal system 
Musculo-skeletal system 
Multiple anomalies 
Chromosomal disorders 
Metabolic disorders  
Urinary tract  
Other 
PRE-VIABLE. Babies (less than 22 weeks) who are non-viable at birth because of gestation but 
who show signs of life. 
 
RESPIRATORY DISORDERS. Severe pulmonary immaturity will encompass those babies 
where structural lung immaturity is so gross as to mean ventilatory support is unsustainable at the 
outset, usually babies between 22 – 24w gestation. Surfactant Deficient Lung Disease may 
include babies with clinical or pathological evidence of hyaline membrane disease.  
Severe pulmonary immaturity 
Surfactant deficiency lung disease 
Pulmonary hypoplasia 
Meconium aspiration syndrome 
Primary persistent pulmonary hypertension 
Chronic lung disease / BPD 
Other (includes pulmonary haemorrhage) 
GASTRO-INTESTINAL DISEASE. Many babies with NEC will have associated sepsis which 
may be given as a secondary cause.  
Necrotising enterocolitis (NEC) 
Other 
NEUROLOGICAL DISORDER. HIE includes those babies with severe hypoxic-ischaemic 
brain injury before birth. If possible, please specify if HIE was primarily of intrapartum or 
antepartum origin. Specify periventricular leukomalacia only if this is a significant factor in the 
infant death. Birth Trauma will usually be classified here.  
Hypoxic-ischaemic encephalopathy (HIE) 
Intraventricular/Periventricular haemorrhage 
Other 
 
INFECTION. Where possible specify the location of infection and whether due to bacteria, virus, 
fungus or other specific organism.   
If infection was the main cause of death please specify whether infection is congenital (i.e. 
acquired ante or intrapartum acquired) or neonatal in origin. 
Generalised (sepsis) 
Pneumonia 
Meningitis 
Other 
 
INJURY / TRAUMA. Post natal trauma only including iatrogenic injury. ‘Birth Trauma’ will 
usually be classified under neurological disorder e.g. HIE; the obstetric classification identifying 
the timing of the injury.  
 
OTHER SPECIFIC CAUSES. Death due to specific fetal and neonatal conditions such as 
isoimmunisation or unexplained hydrops. Neonatal conditions will include aspiration, unexplained 
pulmonary haemorrhage.  
Malignancies/Tumours 
Specific conditions 
SUDDEN UNEXPECTED DEATHS. SIDS should conform to the accepted definition. 
Unascertained are those unexpected deaths that are not explained despite a full investigation 
including autopsy, but do not conform to the accepted definition of SIDS. 
Sudden Infant Death Syndrome (SIDS) 
Infant deaths – cause unascertained 
UNCLASSIFIED.  Cases where little or nothing is known about the pregnancy or delivery and 
which cannot be fitted into any of the above categories. Please use this category as sparingly as 
possible.  
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